{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["SuppData2"],"not_rendered":{"external_links":1},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"SuppData2","index":0,"n_rows":826,"n_cols":5,"rows_kept":826,"flags":["formulas_cached_only"]}
["¬© 2000-2023 QIAGEN. All rights reserved."]
[]
["Ingenuity Canonical Pathways"," -log(p-value)","Ratio","z-score","Molecules"]
["Neutrophil degranulation","2.58E01","1.24E-01",6.9,"ABCA13,AGA,ALDOA,ARG1,AZU1,BPI,C3AR1,CAMP,CDA,CEACAM1,CEACAM3,CEACAM6,CEACAM8,CHIT1,CLEC4D,CLEC5A,CST3,CTSD,CTSG,CYB5R3,CYSTM1,DEFA1 (includes others),DEFA4,DYNLT1,ELANE,FCER1G,FCGR2A,FCGR3A/FCGR3B,FPR1,GPI,HPSE,HSPA1A/HSPA1B,HSPA6,KRT1,LRG1,LTF,LYZ,MMP8,MPO,MS4A3,OLFM4,ORM1,PADI2,PGLYRP1,PKM,PRTN3,QSOX1,RETN,RNASE2,S100A12,S100A8,S100A9,S100P,SERPINB10,SLC2A5,SLPI,TCN1,TNFAIP6,TTR"]
["Amyloid fiber formation","9.05E00","1.92E-01",2.673,"APOA4,CST3,FGA,H2AC14,H2AX,H2BC13,H2BC14,H2BC17,LTF,LYZ,PSENEN,SAA1,TTR,UBE2L6"]
["Transcriptional regulation of granulopoiesis","7.81E00","2.16E-01",2.53,"CEBPE,E2F1,GFI1,H2AC14,H2AX,H2BC13,H2BC14,H2BC17,KLF5,LEF1,MYB"]
["Interferon alpha/beta signaling","6.25E00","1.55E-01",3.317,"GBP2,HLA-A,IFI35,IFIT2,IFIT3,IFITM2,IFITM3,IRF1,SOCS1,SOCS3,STAT1"]
["Salvage Pathways of Pyrimidine Deoxyribonucleotides","6.16E00","5.56E-01",2.236,"APOBEC3A,APOBEC3B,CDA,TK1,TYMP"]
["LXR/RXR Activation","6.09E00","1.14E-01",-0.577,"ALB,APOA4,CETP,FGA,IL18,LPL,LYZ,MSR1,ORM1,S100A8,SAA1,SAA2,SERPINF1,TTR"]
["Interferon Signaling","5.94E00","2.22E-01",2.121,"IFI35,IFIT3,IFITM2,IFITM3,IRF1,SOCS1,STAT1,TAP1"]
["Cell Cycle Checkpoints","5.91E00","7.72E-02",4.583,"BIRC5,BUB1B,CCNA2,CCNB2,CDC25A,CDK1,CENPA,CHEK1,EXO1,GTSE1,H2AX,H2BC13,H2BC14,H2BC17,KIF2C,NUF2,PLK1,PSMB9,PSME2,SKA1,SPC24"]
["Nucleosome assembly","5.86E00","1.84E-01",2.333,"CENPA,CENPW,H2AC14,H2AX,H2BC13,H2BC14,H2BC17,HJURP,RUVBL1"]
["Interferon gamma signaling","5.83E00","1.28E-01",3.464,"FCGR1A,FCGR1BP,GBP1,GBP2,GBP4,GBP5,GBP6,HLA-A,IRF1,SOCS1,SOCS3,STAT1"]
["DNA Damage/Telomere Stress Induced Senescence","5.36E00","1.61E-01",3,"CCNA2,H1-5,H2AC14,H2AX,H2BC13,H2BC14,H2BC17,HMGA2,LMNB1"]
["Regulation of TLR by endogenous ligand","5.27E00","2.86E-01",2.449,"FGA,FGB,S100A8,S100A9,SFTPA1,SFTPA2"]
["Acute Phase Response Signaling","5.27E00","8.65E-02",1.414,"ALB,C1QA,C1QB,C1QC,CRP,FGA,FGB,IL18,ORM1,SAA1,SAA2,SERPINF1,SERPING1,SOCS1,SOCS3,TTR"]
["Macrophage Classical Activation Signaling Pathway","5.15E00","8.47E-02",1.5,"BPI,CLCF1,CXCL10,CXCL8,CXCL9,GBP2,GBP4,IL18,IL23A,IRF1,PKM,SOCS1,SOCS3,STAT1,TNFSF10,TNFSF13B"]
["Kinetochore Metaphase Signaling Pathway","5.11E00","1.09E-01",1.897,"BIRC5,BUB1B,CDK1,CENPA,CENPW,H2AX,KIF2C,NUF2,PLK1,PTTG1,SKA1,SPC24"]
["Antimicrobial peptides","5.02E00","2.06E-01",2.646,"ATOX1,BPI,CAMP,LTF,PRTN3,S100A8,S100A9"]
["Airway Pathology in Chronic Obstructive Pulmonary Disease","4.8E00","1.02E-01","NaN","CLCF1,CTSG,CXCL8,ELANE,IL18,IL23A,MMP8,MPO,ORM1,PRTN3,TNFSF10,TNFSF13B"]
["DNA methylation","4.68E00","2.31E-01",2.449,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17,UHRF1"]
["Estrogen-mediated S-phase Entry","4.68E00","2.31E-01",1.633,"CCNA2,CCND1,CDC25A,CDK1,E2F1,E2F8"]
["Interleukin-4 and Interleukin-13 signaling","4.38E00","1E-01",0.905,"BIRC5,CCND1,CXCL8,IL18,IL23A,POMC,SAA1,SOCS1,SOCS3,STAT1,ZEB1"]
["Response to elevated platelet cytosolic Ca2+","4.31E00","9.09E-02",2.309,"ALB,ALDOA,CTSW,ECM1,FGA,FGB,IGF2,LGALS3BP,ORM1,QSOX1,SERPING1,SPARC"]
["Neutrophil Extracellular Trap Signaling Pathway","4.28E00","5.74E-02",1.46,"BPI,C1QA,C1QB,C1QC,CAMP,CASP5,COL17A1,CTSG,CXCL8,DEFA1 (includes others),DEFA4,ELANE,FCGR3A/FCGR3B,FPR1,LTF,MPO,NCF1,ORAI3,PLB1,PLCL1,PRTN3,SLC2A1,TSPO"]
["Role of JAK family kinases in IL-6-type Cytokine Signaling","4.12E00","1.14E-01",0.333,"BIRC5,CCND1,CLCF1,CRP,IRF1,POMC,SOCS1,SOCS3,STAT1"]
["DHCR24 Signaling Pathway","4.09E00","8.63E-02",0.577,"ALB,APOA4,CETP,FGA,KLF5,ORM1,POMC,SAA1,SAA2,SERPINF1,THRB,TTR"]
["S100 Family Signaling Pathway","4.02E00","4.53E-02",1.859,"APLNR,C3AR1,CACNG2,CNR2,CREB5,CTSD,CXCL8,DEFA1 (includes others),DEFA4,FCGR1A,FCGR2A,FCGR3A/FCGR3B,FFAR2,FGFRL1,FPR1,GPR183,GPR68,IL18,IL23A,LEF1,MMP8,NCF1,P2RY13,P2RY14,P2RY6,PLCL1,PRKAR1B,PTGDR2,S100A12,S100A8,S100A9,S100P,S1PR2,SERPINF1,TCF7"]
["Surfactant metabolism","3.85E00","2.17E-01",2.236,"SFTPA1,SFTPA2,SFTPB,SFTPC,SLC34A2"]
["Multiple Sclerosis Signaling Pathway","3.74E00","6.76E-02",1.807,"C1QA,C1QB,C1QC,CLCF1,CXCL8,GRIN3A,HLA-A,IL18,IL23A,IL7R,IRF1,MPO,STAT1,TNFSF10,TNFSF13B"]
["Mitotic G1 phase and G1/S transition","3.69E00","8.4E-02",2.714,"CCNA2,CCND1,CDC25A,CDK1,DHFR,E2F1,PSMB9,PSME2,RRM2,TK1,TYMS"]
["HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","3.62E00","8.93E-02",2.53,"CCNA2,CHEK1,EME1,EME2,EXO1,H2AX,H2BC13,H2BC14,H2BC17,RAD51"]
["Pyroptosis Signaling Pathway","3.57E00","9.68E-02",2.333,"AIM2,CASP5,GBP1,GBP2,GBP4,GBP5,IL18,NLRC4,PRKAR1B"]
["Cachexia Signaling Pathway","3.5E00","5.43E-02",3.13,"ALB,CASP5,CLCF1,CRP,CXCL8,FGA,FGB,HSPA1A/HSPA1B,HSPA6,IL18,LPL,MALAT1,POMC,PRKAR1B,PSMB9,PSME2,SOCS3,STAT1,TNFSF10,TNFSF13B"]
["Pre-NOTCH Expression and Processing","3.49E00","1.05E-01",2.121,"CCND1,E2F1,H2AC14,H2AX,H2BC13,H2BC14,H2BC17,ST3GAL4"]
["Activated PKN1 stimulates transcription of AR regulated genes KLK2 and KLK3","3.42E00","1.79E-01",2.236,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17"]
["Class I MHC mediated antigen processing and presentation","3.39E00","5.33E-02",2.683,"FBXO6,FBXO7,FCGR1A,FGA,FGB,HLA-A,KBTBD8,MRC2,NCF1,NCF4,PSMB9,PSME2,RNF182,S100A8,S100A9,SOCS1,SOCS3,TAP1,TRIM69,UBE2L6"]
["SIRT1 negatively regulates rRNA expression","3.35E00","1.72E-01",2.236,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17"]
["ATM Signaling","3.34E00","9E-02",-0.707,"CCNB2,CDC25A,CDK1,CHEK1,CREB5,GADD45G,H2AX,RAD51,ZEB1"]
["Mitotic Prophase","3.25E00","8.74E-02",3,"CCNB2,CDK1,H2AC14,H2AX,H2BC13,H2BC14,H2BC17,LMNB1,PLK1"]
["Ribonucleotide Reductase Signaling Pathway","3.23E00","6.98E-02",1.732,"BIRC5,CCND1,CDC25A,CDK1,CHEK1,CREB5,E2F1,E2F8,FOXM1,H3C3,RRM2,SMARCD3"]
["Serine biosynthesis","3.22E00","3.75E-01","NaN","PSAT1,SERINC1,SERINC5"]
["Meiotic recombination","3.14E00","1.25E-01",2.449,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17,RAD51"]
["Pathogen Induced Cytokine Storm Signaling Pathway","3.04E00","5.12E-02",2.524,"AIM2,CLCF1,COL17A1,CRP,CXCL10,CXCL8,CXCL9,FGA,FGB,IL18,IL23A,IRF1,NLRC4,SLC2A1,SLC2A5,SOCS3,STAT1,TNFSF10,TNFSF13B"]
["G alpha (i) signalling events","3.04E00","5.79E-02",1.291,"APLNR,C3AR1,CNR2,CXCL10,CXCL8,CXCL9,FPR1,GNG8,GPR183,P2RY13,P2RY14,POMC,PTGDR2,S1PR2,SAA1"]
["Atherosclerosis Signaling","3.03E00","7.52E-02","NaN","ALB,APOA4,CXCL8,IL18,LPL,LYZ,MSR1,ORM1,PLB1,S100A8"]
["Inflammasome pathway","3.02E00","2E-01",2,"AIM2,CASP5,IL18,NLRC4"]
["Mitotic Metaphase and Anaphase","2.99E00","5.96E-02",3.742,"BIRC5,BUB1B,CCNB2,CDK1,CENPA,KIF2C,LMNB1,NUF2,PLK1,PSMB9,PSME2,PTTG1,SKA1,SPC24"]
["Class A/1 (Rhodopsin-like receptors)","2.98E00","5.35E-02",0.728,"APLNR,C3AR1,CNR2,CXCL10,CXCL8,CXCL9,EDN1,FFAR2,FPR1,GPR183,GPR68,P2RY13,P2RY14,P2RY6,POMC,PTGDR2,SAA1"]
["PRC2 methylates histones and DNA","2.96E00","1.43E-01",2.236,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17"]
["Role of PKR in Interferon Induction and Antiviral Response","2.95E00","7.35E-02",1.134,"CASP5,E2F1,FCGR1A,HSPA1A/HSPA1B,HSPA6,IL18,IRF1,MARCO,MSR1,STAT1"]
["IL-12 Signaling and Production in Macrophages","2.95E00","5.91E-02",-0.535,"ALB,APOA4,FCGR1A,FCGR2A,FCGR3A/FCGR3B,H3C3,IL18,IL23A,IRF1,LYZ,ORM1,S100A8,SOCS3,STAT1"]
["Senescence-Associated Secretory Phenotype (SASP)","2.87E00","9.59E-02",1.89,"CCNA2,CXCL8,H2AC14,H2AX,H2BC13,H2BC14,H2BC17"]
["RHO GTPases Activate NADPH Oxidases","2.86E00","1.82E-01",2,"NCF1,NCF4,S100A8,S100A9"]
["Macrophage Alternative Activation Signaling Pathway","2.85E00","6.32E-02",0,"ARG1,CREB5,FCER1A,FCER1G,FPR1,H3C3,IL18,LPL,MARCO,SOCS1,SOCS3,STAT1"]
["ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression","2.85E00","1.35E-01",2.236,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17"]
["Complement System","2.85E00","1.35E-01",1,"C1QA,C1QB,C1QC,C3AR1,SERPING1"]
["Meiotic synapsis","2.82E00","1.09E-01",2.449,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17,LMNB1"]
["NoRC negatively regulates rRNA expression","2.8E00","1.32E-01",2.236,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17"]
["Formation of Fibrin Clot (Clotting Cascade)","2.74E00","1.28E-01",2.236,"FGA,FGB,PF4V1,PRTN3,SERPING1"]
["RUNX1 regulates megakaryocyte differentiation and platelet function","2.7E00","1.03E-01","NaN","H2AC14,H2AX,H2BC13,H2BC14,H2BC17,MYL9"]
["Role of CHK Proteins in Cell Cycle Checkpoint Control","2.7E00","1.03E-01",-1.342,"CDC25A,CDK1,CHEK1,E2F1,E2F8,PLK1"]
["Regulation of Insulin-like Growth Factor (IGF) transport and uptake by IGFBPs","2.67E00","7.26E-02",1,"ALB,CST3,CTSG,FAM20A,FGA,IGF2,IGFBP5,QSOX1,SPP1"]
["Role of BRCA1 in DNA Damage Response","2.64E00","8.75E-02",0.447,"CHEK1,E2F1,E2F8,PLK1,RAD51,SMARCD3,STAT1"]
["Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell","2.63E00","5.94E-02",0.577,"CD1C,CD34,COL17A1,FCGR1A,FCGR3A/FCGR3B,HCST,HLA-A,KLRB1,LILRA4,LILRA5,LILRB4,TRAC"]
["MyD88:MAL(TIRAP) cascade initiated on plasma membrane","2.6E00","1.19E-01",2.236,"FGA,FGB,S100A8,S100A9,SOCS1"]
["Transcriptional regulation by RUNX1","2.59E00","6.58E-02",3.162,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17,MYB,PSMB9,PSME2,SMARCD3,SOCS3"]
["Deubiquitination","2.53E00","5.32E-02",2.138,"CCNA2,CDC25A,CDK1,H2AC12,H2AC14,H2BC13,H2BC14,H2BC17,H2BC18,PSMB9,PSME2,RUVBL1,UCHL1,YOD1"]
["Osteoarthritis Pathway","2.52E00","5.51E-02",0.707,"ALPL,CASP5,CREB5,CXCL8,GREM1,H19,LEF1,S100A8,S100A9,S1PR2,SLC39A8,SPP1,TCF7"]
["Pyroptosis","2.52E00","1.48E-01",2,"CASP5,ELANE,IL18,IRF1"]
["Retinoid metabolism and transport","2.51E00","1.14E-01",-0.447,"APOA4,LPL,PLB1,SDC3,TTR"]
["Cyclins and Cell Cycle Regulation","2.49E00","8.24E-02",1.89,"CCNA2,CCNB2,CCND1,CDC25A,CDK1,E2F1,E2F8"]
["Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses","2.47E00","6.33E-02",2,"C1QA,C1QB,C1QC,C3AR1,CLCF1,CXCL8,IL18,NLRC4,TNFSF10,TNFSF13B"]
["Aryl Hydrocarbon Receptor Signaling","2.45E00","6.29E-02",1.633,"ALDH1A1,CCNA2,CCND1,CHEK1,CTSD,CYP2C8,DHFR,E2F1,GSTM5,HSPB1"]
["Role of IL-17A in Psoriasis","2.45E00","2.14E-01","NaN","CXCL8,S100A8,S100A9"]
["DNA damage-induced 14-3-3œÉ Signaling","2.42E00","1.09E-01",0.447,"CASP5,CCNB2,CDK1,CHEK1,E2F1"]
["Regulation of mitotic cell cycle","2.41E00","7.95E-02",2.646,"BUB1B,CCNA2,CDK1,PLK1,PSMB9,PSME2,PTTG1"]
["Role of Osteoblasts in Rheumatoid Arthritis Signaling Pathway","2.37E00","5.28E-02",1.941,"ALPL,CLCF1,CTSD,CTSG,CTSW,CXCL8,IL18,LEF1,MMP8,STAT1,TCF7,TNFSF10,TNFSF13B"]
["CGAS-STING Signaling Pathway","2.32E00","6.43E-02",1.667,"CD274,CLCF1,CXCL8,IL18,IRF1,MAP1LC3A,STAT1,TNFSF10,TNFSF13B"]
["dTMP De Novo Biosynthesis","2.31E00","4E-01","NaN","DHFR,TYMS"]
["Phagosome Formation","2.28E00","3.87E-02",2.502,"APLNR,ARPC1B,C3AR1,CLEC4D,CLEC4E,CNR2,FCER1A,FCER1G,FCGR1A,FCGR2A,FCGR3A/FCGR3B,FFAR2,FPR1,GPR183,GPR68,LIMK2,MARCO,MRC2,MSR1,MYL9,P2RY13,P2RY14,P2RY6,PLB1,PTGDR2,S1PR2,WASF1"]
["Cell Cycle: G2/M DNA Damage Checkpoint Regulation","2.27E00","1E-01",-1,"CCNB2,CDK1,CHEK1,CKS2,PLK1"]
["ESR-mediated signaling","2.26E00","6.78E-02",2.121,"CCND1,CTSD,H2AC14,H2AX,H2BC13,H2BC14,H2BC17,MYB"]
["TCF dependent signaling in response to WNT","2.22E00","5.53E-02",1.508,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17,KREMEN1,LEF1,PSMB9,PSME2,RUVBL1,TCF7"]
["Mitotic G2-G2/M phases","2.22E00","5.53E-02",3.317,"CCNA2,CCNB2,CDC25A,CDK1,E2F1,FOXM1,GTSE1,PLK1,PSMB9,PSME2,TPX2"]
["Natural Killer Cell Signaling","2.21E00","5.5E-02",2.53,"FCER1G,FCGR2A,FCGR3A/FCGR3B,HCST,HLA-A,HSPA1A/HSPA1B,HSPA6,IL18,KLRB1,LIMK2,TNFSF10"]
["Transcriptional regulation by RUNX3","2.2E00","7.29E-02",-0.378,"CCND1,LEF1,PSMB9,PSME2,SPP1,TCF7,ZFHX3"]
["Telomere Maintenance","2.2E00","8.22E-02",2.449,"CCNA2,H2AC14,H2AX,H2BC13,H2BC14,H2BC17"]
["Airway Inflammation in Asthma","2.19E00","1.21E-01","NaN","CXCL8,ELANE,IL23A,RNASE2"]
["B-WICH complex positively regulates rRNA expression","2.19E00","9.62E-02",2.236,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17"]
["Th1 and Th2 Activation Pathway","2.18E00","5.75E-02","NaN","CD274,GFI1,HLA-A,IL18,IRF1,PSENEN,PTGDR2,SOCS1,SOCS3,STAT1"]
["Salvage Pathways of Pyrimidine Ribonucleotides","2.18E00","7.22E-02",2.646,"APOBEC3A,APOBEC3B,CDA,CDK1,LIMK2,NME4,PLK1"]
["DNA Methylation and Transcriptional Repression Signaling","2.15E00","7.14E-02",2.236,"CDK1,E2F1,E2F8,GADD45G,TCF7,UHRF1,ZEB1"]
["Transcriptional Regulation by E2F6","2.15E00","1.18E-01",1,"CHEK1,E2F1,RAD51,RRM2"]
["Th1 Pathway","2.13E00","6.45E-02",1.414,"CD274,HLA-A,IL18,IRF1,PSENEN,SOCS1,SOCS3,STAT1"]
["Tumor Microenvironment Pathway","2.07E00","5.52E-02",0,"ARG1,CCND1,CD274,CXCL8,HLA-A,IGF2,MMP8,PDCD1LG2,SLC2A1,SPP1"]
["RHO GTPases activate CIT","2.07E00","1.58E-01","NaN","CIT,DLG4,MYL9"]
["IL-10 Signaling","2.06E00","5.84E-02",1,"CCND1,CREB5,FCGR2A,FFAR2,HLA-A,IL18,PKM,SOCS3,STAT1"]
["HIF1Œ± Signaling","2.04E00","5.21E-02",-0.302,"CAMK4,EDN1,GPI,HSPA1A/HSPA1B,HSPA6,IGF2,MMP8,NCF1,PKM,SLC2A1,SLC2A5"]
["DNA Replication Pre-Initiation","2.02E00","6.73E-02",2.646,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17,PSMB9,PSME2"]
["Detoxification of Reactive Oxygen Species","2.02E00","1.08E-01",2,"ATOX1,GPX1,NCF1,NCF4"]
["IL-7 Signaling Pathway","2.01E00","7.5E-02",-1.342,"CCND1,CDC25A,IL7R,SLC2A1,SOCS1,STAT1"]
["TR/RXR Activation","2.01E00","6.15E-02",-0.707,"CAMK4,CCNA2,CCND1,FGA,FOXM1,H3C3,SLC2A1,THRB"]
["Cell Cycle Regulation by BTG Family Proteins","1.98E00","1.05E-01","NaN","CCND1,E2F1,E2F8,NOCT"]
["Extracellular matrix organization","1.97E00","6.6E-02",1.134,"ADAM19,CEACAM1,CEACAM6,CEACAM8,NID1,SPARC,TTR"]
["Post-translational protein phosphorylation","1.95E00","6.54E-02",1.134,"ALB,CST3,FAM20A,FGA,IGFBP5,QSOX1,SPP1"]
["Autism Signaling Pathway","1.93E00","4.52E-02",0,"ALDH1A1,ATP7B,CACNG2,CLCF1,CXCL8,GRIN3A,HLA-A,IGF2,IL18,LEF1,PRKAR1B,TCF7,TNFSF10,TNFSF13B"]
["Production of Nitric Oxide and Reactive Oxygen Species in Macrophages","1.88E00","5.18E-02",1.667,"ALB,APOA4,IRF1,LYZ,MPO,NCF1,NCF4,ORM1,S100A8,STAT1"]
["TRAIL signaling","1.88E00","2.5E-01","NaN","TNFRSF10A,TNFSF10"]
["Role of JAK2 in Hormone-like Cytokine Signaling","1.88E00","8.06E-02",-0.447,"CCND1,POMC,SOCS1,SOCS3,STAT1"]
["Oxidative Stress Induced Senescence","1.87E00","6.98E-02",2.449,"E2F1,H2AC14,H2AX,H2BC13,H2BC14,H2BC17"]
["Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza","1.87E00","6.98E-02",1.633,"CXCL10,CXCL8,IFIT2,IFIT3,IL18,STAT1"]
["White Adipose Tissue Browning Pathway","1.86E00","5.8E-02",0,"CACNG2,CAMP,CREB5,FCER1A,FCER1G,FGFRL1,PRKAR1B,THRB"]
["RHO GTPases Activate Formins","1.85E00","5.76E-02",2.828,"BIRC5,BUB1B,CENPA,KIF2C,NUF2,PLK1,SKA1,SPC24"]
["Metabolism of porphyrins","1.83E00","1.3E-01","NaN","ALAS1,ALB,FECH"]
["Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I","1.83E00","1.3E-01","NaN","NME4,RRM2,TYMS"]
["GŒ±i Signaling","1.83E00","5.71E-02",-0.378,"APLNR,CNR2,FPR1,GNA15,P2RY13,P2RY14,PRKAR1B,RAP1GAP"]
["PXR/RXR Activation","1.8E00","7.69E-02",2.236,"ABCB11,ALAS1,ALDH1A1,CYP2C8,PRKAR1B"]
["Signaling by SCF-KIT","1.79E00","9.3E-02",2,"CHEK1,PTPRU,SOCS1,STAT1"]
["Interleukin-6 family signaling","1.78E00","1.25E-01","NaN","CLCF1,SOCS3,STAT1"]
["Growth hormone receptor signaling","1.78E00","1.25E-01","NaN","SOCS1,SOCS3,STAT1"]
["Interleukin-1 processing","1.78E00","2.22E-01","NaN","CTSG,IL18"]
["Pathogenesis of Multiple Sclerosis","1.78E00","2.22E-01","NaN","CXCL10,CXCL9"]
["Heme Biosynthesis II","1.78E00","2.22E-01","NaN","ALAS1,FECH"]
["Degradation of the extracellular matrix","1.77E00","7.58E-02",2.236,"CTSG,ELANE,MMP8,NID1,SPP1"]
["Hereditary Breast Cancer Signaling","1.76E00","5.56E-02","NaN","CCND1,CDK1,CHEK1,E2F1,GADD45G,H2AX,RAD51,SMARCD3"]
["TP53 Regulates Transcription of Cell Death Genes","1.76E00","9.09E-02",0,"BIRC5,BNIP3L,NLRC4,TNFRSF10A"]
["ID1 Signaling Pathway","1.74E00","4.93E-02",-1.265,"BHLHA15,BIRC5,CCND1,E2F1,FGFRL1,IGF2,RAP1GAP,S100A9,STMN3,TYMS"]
["Mitotic Prometaphase","1.74E00","4.93E-02",3.162,"BIRC5,BUB1B,CCNB2,CDK1,CENPA,KIF2C,NUF2,PLK1,SKA1,SPC24"]
["Mitotic Roles of Polo-Like Kinase","1.74E00","7.46E-02",1.342,"CCNB2,CDC25A,CDK1,PLK1,PTTG1"]
["CDX Gastrointestinal Cancer Signaling Pathway","1.73E00","4.9E-02",1.265,"CCND1,CLCF1,CXCL8,IL18,KLF5,LEF1,NCF1,TCF7,TNFSF10,TNFSF13B"]
["Interleukin-10 signaling","1.73E00","8.89E-02",1,"CXCL10,CXCL8,FPR1,IL18"]
["cAMP-mediated signaling","1.71E00","4.66E-02",-0.905,"APLNR,CAMK4,CNR2,CREB5,FPR1,P2RY13,P2RY14,PDE7B,PDE9A,PRKAR1B,RAP1GAP"]
["EPH-Ephrin signaling","1.69E00","6.38E-02",2.449,"ARPC1B,CLTCL1,EPHA1,LIMK2,MYL9,PSENEN"]
["mRNA Editing","1.69E00","2E-01","NaN","APOBEC3A,APOBEC3B"]
["Endocannabinoid Cancer Inhibition Pathway","1.68E00","5.37E-02",0.378,"CASP5,CCND1,CNR2,CREB5,LEF1,PRKAR1B,SMPD1,TCF7"]
["Gene Silencing by RNA","1.67E00","6.32E-02",2.449,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17,PIWIL4"]
["Prolactin Signaling","1.65E00","6.25E-02",-0.447,"IRF1,KCNMA1,SOCS1,SOCS3,STAT1,TCF7"]
["Melatonin Degradation III","1.64E00","1E00","NaN","MPO"]
["Glycolysis I","1.64E00","1.11E-01","NaN","ALDOA,GPI,PKM"]
["Nonhomologous End-Joining (NHEJ)","1.6E00","8.16E-02",2,"H2AX,H2BC13,H2BC14,H2BC17"]
["TP53 Regulates Transcription of Cell Cycle Genes","1.6E00","8.16E-02",2,"CCNA2,CDK1,E2F1,E2F8"]
["p53 Signaling","1.58E00","6E-02",-2,"BIRC5,CCND1,CHEK1,E2F1,GADD45G,TNFRSF10A"]
["S Phase","1.58E00","6E-02",1.633,"CCNA2,CCND1,CDC25A,E2F1,PSMB9,PSME2"]
["Signaling by NOTCH3","1.58E00","8E-02",0,"HEY2,NEURL1,PSENEN,STAT1"]
["Dopamine-DARPP32 Feedback in cAMP Signaling","1.57E00","4.84E-02",0.447,"CACNG2,CAMK4,CREB5,GRIN3A,KCNJ10,KCNJ15,KCNJ2,PLCL1,PRKAR1B"]
["TNFs bind their physiological receptors","1.56E00","1.03E-01","NaN","CD27,TNFRSF13B,TNFSF13B"]
["IL-33 Signaling Pathway","1.56E00","4.81E-02",1.134,"CASP5,CREB5,CTSG,CXCL8,ELANE,H2AX,H2BC17,IL18,PRKAR1B"]
["FXR/RXR Activation","1.56E00","4.81E-02",0.333,"ABCB11,CLCF1,CXCL8,GSTM5,IL18,LPL,SOCS3,TNFSF10,TNFSF13B"]
["NOD1/2 Signaling Pathway","1.54E00","4.76E-02",1.667,"CLCF1,CXCL8,DEFA1 (includes others),DEFA4,HSPA1A/HSPA1B,HSPA6,IL18,TNFSF10,TNFSF13B"]
["Granulocyte Adhesion and Diapedesis","1.54E00","4.76E-02","NaN","CDH5,CLDN11,CXCL10,CXCL8,CXCL9,FPR1,IL18,MMP8,SDC3"]
["Signaling by CSF3 (G-CSF)","1.52E00","1E-01","NaN","SOCS1,SOCS3,STAT1"]
["IL-6 Signaling","1.52E00","5.34E-02",0.378,"CRP,CXCL8,HSPB1,IL18,SOCS1,SOCS3,TNFAIP6"]
["TREM1 Signaling","1.51E00","6.49E-02",1.342,"CASP5,CXCL8,IL18,MPO,NLRC4"]
["Toll-like Receptor Cascades","1.49E00","9.68E-02","NaN","BPI,SFTPA1,SFTPA2"]
["Sonic Hedgehog Signaling","1.49E00","9.68E-02","NaN","CCNB2,CDK1,PRKAR1B"]
["Hepatic Fibrosis / Hepatic Stellate Cell Activation","1.47E00","4.64E-02","NaN","BAMBI,COL17A1,CXCL8,CXCL9,EDN1,IGF2,IGFBP5,MYL9,STAT1"]
["Maturity Onset Diabetes of Young (MODY) Signaling","1.47E00","6.33E-02","NaN","APOA4,APOL2,APOL4,APOL6,CACNG2"]
["Metabolism of folate and pterines","1.47E00","1.54E-01","NaN","DHFR,MTHFD2L"]
["Advanced glycosylation endproduct receptor signaling","1.47E00","1.54E-01","NaN","S100A12,SAA1"]
["Phagosome Maturation","1.47E00","4.88E-02","NaN","CTSD,CTSG,CTSW,DYNLT1,HLA-A,MPO,NCF1,TAP1"]
["Complement cascade","1.46E00","5.19E-02",2.646,"C1QA,C1QB,C1QC,C3AR1,CRP,ELANE,SERPING1"]
["HOTAIR Regulatory Pathway","1.45E00","4.85E-02",0.378,"FOXM1,H3C3,IRF1,JAM2,LEF1,MMP8,SPP1,TCF7"]
["Acetylcholine Receptor Signaling Pathway","1.45E00","4.59E-02",-1,"ADAM19,CACNG2,CASP5,CREB5,GNA15,KCNJ2,PLCL1,PRKAR1B,PSENEN"]
["E3 ubiquitin ligases ubiquitinate target proteins","1.44E00","7.27E-02",2,"H2BC13,H2BC14,H2BC17,HLA-A"]
["Activation of anterior HOX genes in hindbrain during early embryogenesis","1.43E00","6.17E-02",2.236,"H2AC14,H2AX,H2BC13,H2BC14,H2BC17"]
["Activation of Matrix Metalloproteinases","1.42E00","9.09E-02","NaN","CTSG,ELANE,MMP8"]
["LGI-ADAM interactions","1.41E00","1.43E-01","NaN","CACNG2,DLG4"]
["Aspirin ADME","1.41E00","1.43E-01","NaN","ALB,CYP2C8"]
["Formation of axial mesoderm","1.41E00","1.43E-01","NaN","LEF1,TCF7"]
["Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis","1.37E00","3.89E-02","NaN","CCND1,CEBPE,CREB5,CXCL8,FCGR1A,FCGR3A/FCGR3B,IL18,LEF1,PLCL1,SOCS1,SOCS3,TCF7,TNFSF13B"]
["Senescence Pathway","1.36E00","3.99E-02",-0.302,"CACNG2,CCNB2,CCND1,CDC25A,CDK1,CHEK1,CXCL8,E2F1,E2F8,GADD45G,SAA1,SAA2"]
["Transport of glycerol from adipocytes to the liver by Aquaporins","1.35E00","5E-01","NaN","AQP9"]
["Thyroid Hormone Biosynthesis","1.35E00","5E-01","NaN","CTSD"]
["DNA Double Strand Break Response","1.35E00","6.78E-02",2,"H2AX,H2BC13,H2BC14,H2BC17"]
["GABA receptor activation","1.33E00","6.67E-02",2,"GNG8,KCNJ10,KCNJ15,KCNJ2"]
["Caspase activation via Death Receptors in the presence of ligand","1.3E00","1.25E-01","NaN","TNFRSF10A,TNFSF10"]
["Signal regulatory protein family interactions","1.3E00","1.25E-01","NaN","SFTPA1,SFTPA2"]
["Extrinsic Prothrombin Activation Pathway","1.3E00","1.25E-01","NaN","FGA,FGB"]
["Agranulocyte Adhesion and Diapedesis","1.29E00","4.29E-02","NaN","CD34,CDH5,CLDN11,CXCL10,CXCL8,CXCL9,IL18,MMP8,MYL9"]
["Role of Osteoclasts in Rheumatoid Arthritis Signaling Pathway","1.29E00","3.87E-02",1.265,"ADAM19,CAMK4,CCND1,COL17A1,CREB5,FCGR1A,FCGR2A,FCGR3A/FCGR3B,HCST,IL18,MMP8,SPP1"]
["Cell surface interactions at the vascular wall","1.28E00","4.27E-02",1.667,"CEACAM1,CEACAM3,CEACAM6,CEACAM8,FCER1G,JAM2,PF4V1,SDC3,TNFRSF10A"]
["IL-8 Signaling","1.27E00","4.25E-02",1.134,"AZU1,CCND1,CXCL8,DEFA1 (includes others),GNA15,LIMK2,MPO,MYL9,NCF1"]
["Opioid Signalling","1.27E00","5.56E-02",1.342,"CAMK4,GNA15,GNG8,POMC,PRKAR1B"]
["Breast Cancer Regulation by Stathmin1","1.26E00","3.36E-02",0.894,"APLNR,C3AR1,CAMK4,CCND1,CDK1,CNR2,CREB5,E2F1,E2F8,FFAR2,FOXM1,FPR1,GPR183,GPR68,P2RY13,P2RY14,P2RY6,PRKAR1B,PTGDR2,S1PR2"]
["Germ layer formation at gastrulation","1.25E00","1.18E-01","NaN","LEF1,TCF7"]
["D-myo-inositol (1,3,4)-trisphosphate Biosynthesis","1.25E00","1.18E-01","NaN","INPP5F,MINPP1"]
["Chronic Myeloid Leukemia Signaling","1.25E00","3.93E-02",0.302,"BIRC5,CCND1,E2F1,E2F8,FOXM1,LEF1,PLCL1,PLK1,SPP1,TCF7,TNFSF10"]
["Semaphorin interactions","1.24E00","6.25E-02",0,"DPYSL3,LIMK2,MYL9,SEMA7A"]
["Antigen Presentation Pathway","1.23E00","7.69E-02","NaN","HLA-A,PSMB9,TAP1"]
["Metabolism of Angiotensinogen to Angiotensins","1.21E00","1.11E-01","NaN","CTSD,CTSG"]
["Docosahexaenoic Acid (DHA) Signaling","1.2E00","3.97E-02",0,"ALB,CCND1,CREB5,KCNMA1,PLB1,PLCL1,PRKAR1B,PSENEN,SERPINF1,TNFAIP2"]
["FcŒ≥ Receptor-mediated Phagocytosis in Macrophages and Monocytes","1.2E00","5.32E-02",2.236,"ARPC1B,FCGR1A,FCGR2A,FCGR3A/FCGR3B,NCF1"]
["RHOA Signaling","1.2E00","4.84E-02",2.236,"ARPC1B,CIT,EPHA1,LIMK2,MYL9,WASF1"]
["Lactose synthesis","1.18E00","3.33E-01","NaN","SLC2A1"]
["Serine Biosynthesis","1.18E00","3.33E-01","NaN","PSAT1"]
["Ascorbate Recycling (Cytosolic)","1.18E00","3.33E-01","NaN","GLRX"]
["RHO GTPases Activate ROCKs","1.17E00","1.05E-01","NaN","LIMK2,MYL9"]
["RAR Activation","1.16E00","3.48E-02",0.775,"ALDH1A1,CLCF1,CREB5,CXCL8,DHRS9,GNA15,IL18,MMP8,PDE7B,PDE9A,PRKAR1B,SMARCD3,SOCS3,TNFSF10,TNFSF13B"]
["Cell Cycle: G1/S Checkpoint Regulation","1.16E00","5.88E-02",-1,"CCND1,CDC25A,E2F1,E2F8"]
["Pancreatic Adenocarcinoma Signaling","1.14E00","4.69E-02","NaN","BIRC5,CCND1,E2F1,E2F8,RAD51,STAT1"]
["Ovarian Cancer Signaling","1.14E00","4.37E-02","NaN","CCND1,E2F1,EDN1,LEF1,PRKAR1B,RAD51,TCF7"]
["Assembly and cell surface presentation of NMDA receptors","1.13E00","6.98E-02","NaN","DLG4,GRIN3A,LIN7A"]
["Interleukin-12 family signaling","1.13E00","1E-01","NaN","IL23A,STAT1"]
["Class I peroxisomal membrane protein import","1.13E00","1E-01","NaN","ABCD2,PXMP2"]
["Role of JAK1 and JAK3 in Œ≥c Cytokine Signaling","1.13E00","5.71E-02","NaN","IL7R,SOCS1,SOCS3,STAT1"]
["Synaptic Long Term Potentiation","1.09E00","4.55E-02",1.342,"CAMK4,CREB5,GNA15,GRIN3A,PLCL1,PRKAR1B"]
["Growth Hormone Signaling","1.09E00","5.56E-02","NaN","IGF2,SOCS1,SOCS3,STAT1"]
["Interleukin-7 signaling","1.09E00","9.52E-02","NaN","IL7R,SOCS1"]
["Nucleotide salvage","1.09E00","9.52E-02","NaN","CDA,TK1"]
["Neurovascular Coupling Signaling Pathway","1.08E00","3.88E-02",3,"CACNG2,ENTPD7,GRIN3A,KCNJ10,KCNJ15,KCNJ2,KCNMA1,PLB1,PRKAR1B"]
["G-Protein Coupled Receptor Signaling","1.08E00","3.12E-02",0.853,"APLNR,C3AR1,CAMK4,CARD10,CCND1,CNR2,CREB5,FFAR2,FPR1,GNA15,GPR183,GPR68,MYL9,P2RY13,P2RY14,P2RY6,PDE7B,PDE9A,PRKAR1B,PTGDR2,RAP1GAP,S1PR2"]
["Potassium Channels","1.07E00","4.85E-02",2.236,"GNG8,KCNJ10,KCNJ15,KCNJ2,KCNMA1"]
["Adrenergic Receptor Signaling Pathway (Enhanced)","1.06E00","4E-02",-0.707,"CACNG2,CLCF1,CXCL8,IL18,PLCL1,PRKAR1B,TNFSF10,TNFSF13B"]
["Heme Biosynthesis from Uroporphyrinogen-III I","1.06E00","2.5E-01","NaN","FECH"]
["Glutathione Redox Reactions II","1.06E00","2.5E-01","NaN","GLRX"]
["Rapoport-Luebering Glycolytic Shunt","1.06E00","2.5E-01","NaN","MINPP1"]
["Cellular hexose transport","1.05E00","9.09E-02","NaN","SLC2A1,SLC45A3"]
["Interconversion of nucleotide di- and triphosphates","1.05E00","9.09E-02","NaN","GLRX,NME4"]
["Superpathway of D-myo-inositol (1,4,5)-trisphosphate Metabolism","1.05E00","9.09E-02","NaN","INPP5F,MINPP1"]
["Role of IL-17F in Allergic Inflammatory Airway Diseases","1.04E00","6.38E-02","NaN","CREB5,CXCL10,CXCL8"]
["Plasma lipoprotein assembly, remodeling, and clearance","1.02E00","5.26E-02",-1,"ALB,APOA4,CETP,LPL"]
["Vitamin-C Transport","1.02E00","8.7E-02","NaN","GLRX,SLC2A1"]
["Retinol Biosynthesis","1.02E00","6.25E-02","NaN","DHRS9,LPL,PLB1"]
["Leptin Signaling in Obesity","1.01E00","5.19E-02","NaN","PLCL1,POMC,PRKAR1B,SOCS3"]
["ISGylation Signaling Pathway","1E00","4.63E-02",2.236,"BIRC5,CCND1,IRF1,STAT1,UBE2L6"]
["Signaling by VEGF","1E00","4.63E-02",1.342,"CDH5,HSPB1,NCF1,NCF4,WASF1"]
["PFKFB4 Signaling Pathway","1E00","6.12E-02","NaN","CREB5,GPI,PRKAR1B"]
["VDR/RXR Activation","9.93E-01","5.13E-02","NaN","CAMP,CXCL10,IGFBP5,SPP1"]
["AMPK Signaling","9.93E-01","3.72E-02",1.134,"CCNA2,CCND1,CREB5,GNA15,PFKFB3,PRKAR1B,RAB39A,SLC2A1,SMARCD3"]
["Regulation of RUNX1 Expression and Activity","9.9E-01","8.33E-02","NaN","CCND1,H19"]
["IL-22 Signaling","9.9E-01","8.33E-02","NaN","SOCS3,STAT1"]
["G alpha (q) signalling events","9.8E-01","4E-02",1.134,"EDN1,FFAR2,GNA15,GNG8,GPR68,P2RY6,SAA1"]
["Thyroid Cancer Signaling","9.78E-01","5.06E-02",-2,"CCND1,CXCL8,LEF1,TCF7"]
["Opioid Signaling Pathway","9.71E-01","3.57E-02",0.378,"CACNG2,CAMK4,CLTCL1,CREB5,GNA15,GRIN3A,LEF1,POMC,PRKAR1B,TCF7"]
["Intestinal absorption","9.65E-01","2E-01","NaN","SLC2A5"]
["Protein Citrullination","9.65E-01","2E-01","NaN","PADI2"]
["Superpathway of Serine and Glycine Biosynthesis I","9.65E-01","2E-01","NaN","PSAT1"]
["Tetrahydrofolate Salvage from 5,10-methenyltetrahydrofolate","9.65E-01","2E-01","NaN","MTHFD2L"]
["Tetrapyrrole Biosynthesis II","9.65E-01","2E-01","NaN","ALAS1"]
["Myo-inositol Biosynthesis","9.65E-01","2E-01","NaN","INPP5F"]
["Arginine Degradation I (Arginase Pathway)","9.65E-01","2E-01","NaN","ARG1"]
["Glucose metabolism","9.63E-01","5E-02",2,"ALDOA,GPI,PFKFB3,PKM"]
["Transcriptional regulation by RUNX2","9.61E-01","5.88E-02","NaN","CCND1,CDK1,HEY2"]
["Neuroinflammation Signaling Pathway","9.48E-01","3.45E-02",1.897,"BIRC5,CREB5,CRP,CXCL10,CXCL8,GRIN3A,HLA-A,IL18,NCF1,PSENEN,STAT1"]
["C-type lectin receptors (CLRs)","9.46E-01","4.14E-02",2,"CLEC4D,CLEC4E,FCER1G,MUC3A,PSMB9,PSME2"]
["BEX2 Signaling Pathway","9.34E-01","4.88E-02",-1,"CCND1,LEF1,SPP1,TCF7"]
["Interleukin-20 family signaling","9.32E-01","7.69E-02","NaN","SOCS3,STAT1"]
["IL-17A Signaling in Gastric Cells","9.32E-01","7.69E-02","NaN","CXCL10,CXCL8"]
["Role of JAK1, JAK2 and TYK2 in Interferon Signaling","9.32E-01","7.69E-02","NaN","SOCS1,STAT1"]
["Antioxidant Action of Vitamin C","9.28E-01","4.39E-02","NaN","GLRX,PLB1,PLCL1,SLC2A1,SLC2A5"]
["Huntington's Disease Signaling","9.27E-01","3.5E-02","NaN","CASP5,CLTCL1,CREB5,CTSD,DLG4,GNA15,HSPA1A/HSPA1B,HSPA6,PSMB9,PSME2"]
["Regulation of Apoptosis","9.24E-01","5.66E-02","NaN","OPA1,PSMB9,PSME2"]
["D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis","9.24E-01","3.87E-02",0,"ALPL,CDC25A,INPP5F,MINPP1,NOCT,PLPP6,SOCS3"]
["D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis","9.24E-01","3.87E-02",0,"ALPL,CDC25A,INPP5F,MINPP1,NOCT,PLPP6,SOCS3"]
["Signaling by NOTCH4","9.2E-01","4.82E-02",1,"HEY2,PSENEN,PSMB9,PSME2"]
["Molecular Mechanisms of Cancer","9.15E-01","2.92E-02",0.2,"APLNR,C3AR1,CCND1,CDC25A,CHEK1,CNR2,E2F1,E2F8,EDN1,FFAR2,FPR1,GNA15,GPR183,GPR68,IL7R,LEF1,MMP8,P2RY13,P2RY14,P2RY6,PRKAR1B,PSENEN,PTGDR2,S1PR2,TCF7"]
["Transcriptional regulation of white adipocyte differentiation","9.06E-01","4.76E-02",0,"ADIRF,KLF5,LPL,SMARCD3"]
["Role of Cytokines in Mediating Communication between Immune Cells","9.06E-01","5.56E-02","NaN","CXCL8,IL18,IL23A"]
["Endocannabinoid Neuronal Synapse Pathway","9.05E-01","4.03E-02",-0.816,"CACNG2,CNR2,GNA15,GRIN3A,PLCL1,PRKAR1B"]
["BMAL1:CLOCK,NPAS2 activates circadian gene expression","9.04E-01","7.41E-02","NaN","NOCT,SMARCD3"]
["Integrin signaling","9.04E-01","7.41E-02","NaN","FGA,FGB"]
["Gluconeogenesis I","9.04E-01","7.41E-02","NaN","ALDOA,GPI"]
["Apelin Liver Signaling Pathway","9.04E-01","7.41E-02","NaN","APLNR,EDN1"]
["Integrin cell surface interactions","8.93E-01","4.71E-02",1,"FGA,FGB,JAM2,SPP1"]
["BAG2 Signaling Pathway","8.93E-01","4.71E-02","NaN","HSPA1A/HSPA1B,HSPA6,PSMB9,PSME2"]
["Fructose metabolism","8.9E-01","1.67E-01","NaN","ALDH1A1"]
["GDP-mannose Biosynthesis","8.9E-01","1.67E-01","NaN","GPI"]
["Calcium Signaling","8.88E-01","3.64E-02",0,"ATP2B1,CACNG2,CAMK4,CREB5,GRIN3A,MYL9,PRKAR1B,TNNT3"]
["Sirtuin Signaling Pathway","8.85E-01","3.42E-02",0.707,"AGTRAP,CXCL8,E2F1,GADD45G,H1-5,H3C3,MAP1LC3A,PFKFB3,SLC2A1,TSPO"]
["GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells","8.82E-01","4.24E-02",0.447,"CACNG2,FFAR2,GNA15,PLCL1,PRKAR1B"]
["Platelet homeostasis","8.8E-01","4.65E-02",0,"ATP2B1,GNG8,KCNMA1,PDE9A"]
["SUMOylation of intracellular receptors","8.78E-01","7.14E-02","NaN","NR3C2,THRB"]
["Corticotropin Releasing Hormone Signaling","8.76E-01","3.95E-02",0.816,"CACNG2,CAMK4,CREB5,KRT1,POMC,PRKAR1B"]
["Factors Promoting Cardiogenesis in Vertebrates","8.66E-01","3.92E-02",-1.633,"CCND1,CREB5,GJA5,LEF1,PLCL1,TCF7"]
["Hepatic Cholestasis","8.64E-01","3.59E-02",0,"ABCB11,CETP,CLCF1,CXCL8,IL18,PRKAR1B,TNFSF10,TNFSF13B"]
["p38 MAPK Signaling","8.6E-01","4.17E-02",2.236,"CREB5,H3C3,HSPB1,IL18,STAT1"]
["Neuroprotective Role of THOP1 in Alzheimer's Disease","8.49E-01","4.13E-02",1,"CTSG,HLA-A,PRKAR1B,PRSS57,PRTN3"]
["MSP-RON Signaling in Macrophages Pathway","8.49E-01","4.13E-02",1.342,"ARG1,CREB5,SOCS1,SOCS3,STAT1"]
["Triacylglycerol Degradation","8.39E-01","5.17E-02","NaN","LPL,PLB1,TNFAIP6"]
["Activation of kainate receptors upon glutamate binding","8.3E-01","6.67E-02","NaN","DLG4,GNG8"]
["Nucleotide catabolism","8.3E-01","6.67E-02","NaN","ENTPD7,TYMP"]
["FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","8.3E-01","6.67E-02","NaN","POMC,RETN"]
["3-phosphoinositide Degradation","8.29E-01","3.65E-02",0,"ALPL,CDC25A,INPP5F,MINPP1,NOCT,PLPP6,SOCS3"]
["Immunogenic Cell Death Signaling Pathway","8.29E-01","4.44E-02",2,"CXCL10,FPR1,HSPA1A/HSPA1B,HSPA6"]
["Erythrocytes take up oxygen and release carbon dioxide","8.28E-01","1.43E-01","NaN","RHAG"]
["Urea Cycle","8.28E-01","1.43E-01","NaN","ARG1"]
["Arginine Degradation VI (Arginase 2 Pathway)","8.28E-01","1.43E-01","NaN","ARG1"]
["Signaling by ERBB4","8.24E-01","5.08E-02","NaN","DLG4,PSENEN,SPARC"]
["Metabolism of water-soluble vitamins and cofactors","8.24E-01","5.08E-02","NaN","CYB5R3,SLC2A1,TCN1"]
["Degradation of beta-catenin by the destruction complex","8.16E-01","4.4E-02","NaN","LEF1,PSMB9,PSME2,TCF7"]
["Apelin Adipocyte Signaling Pathway","8.16E-01","4.4E-02","NaN","APLNR,GPX1,NCF1,PRKAR1B"]
["CREB Signaling in Neurons","8.09E-01","2.96E-02",0.243,"APLNR,C3AR1,CACNG2,CAMK4,CNR2,CREB5,FFAR2,FPR1,GNA15,GPR183,GPR68,P2RY13,P2RY14,P2RY6,PLCL1,PRKAR1B,PTGDR2,S1PR2"]
["Primary Immunodeficiency Signaling","8.08E-01","5E-02","NaN","IL7R,TAP1,TNFRSF13B"]
["Retinoic acid Mediated Apoptosis Signaling","8.08E-01","5E-02","NaN","IRF1,TNFRSF10A,TNFSF10"]
["GADD45 Signaling","8.08E-01","5E-02","NaN","CCND1,CDK1,GADD45G"]
["Asparagine N-linked glycosylation","8.07E-01","6.45E-02","NaN","ASGR1,FUT8"]
["Leukocyte Extravasation Signaling","8.05E-01","3.59E-02",1.342,"CDH5,CLDN11,JAM2,MMP8,NCF1,NCF4,RAP1GAP"]
["Cell junction organization","8.04E-01","4.35E-02",0,"CD151,CDH5,CLDN11,COL17A1"]
["MAPK6/MAPK4 signaling","8.04E-01","4.35E-02","NaN","CDK1,HSPB1,PSMB9,PSME2"]
["Collagen degradation","7.93E-01","4.92E-02","NaN","COL17A1,ELANE,MMP8"]
["Semaphorin Signaling in Neurons","7.93E-01","4.92E-02","NaN","DPYSL3,LIMK2,SEMA7A"]
["Regulation of TP53 Activity through Phosphorylation","7.92E-01","4.3E-02",2,"CCNA2,CHEK1,EXO1,TPX2"]
["D-myo-inositol-5-phosphate Metabolism","7.89E-01","3.55E-02",0,"ALPL,CDC25A,INPP5F,MINPP1,NOCT,PLPP6,SOCS3"]
["ROBO SLIT Signaling Pathway","7.88E-01","3.94E-02",-0.447,"ARPC1B,ENAH,MYL9,NELL2,PRKAR1B"]
["Glioma Signaling","7.88E-01","3.94E-02","NaN","CAMK4,CCND1,E2F1,E2F8,IGF2"]
["Glutamate binding, activation of AMPA receptors and synaptic plasticity","7.85E-01","6.25E-02","NaN","CACNG2,DLG4"]
["Thrombin signalling through proteinase activated receptors (PARs)","7.85E-01","6.25E-02","NaN","GNA15,GNG8"]
["RIPK1-mediated regulated necrosis","7.85E-01","6.25E-02","NaN","TNFRSF10A,TNFSF10"]
["Dopamine Degradation","7.85E-01","6.25E-02","NaN","ALDH1A1,SULT1A2"]
["Inhibition of ARE-Mediated mRNA Degradation Pathway","7.77E-01","3.68E-02",2.236,"POMC,PRKAR1B,PSMB9,PSME2,TNFSF10,TNFSF13B"]
["Histidine catabolism","7.75E-01","1.25E-01","NaN","CARNS1"]
["Histidine Degradation III","7.75E-01","1.25E-01","NaN","MTHFD2L"]
["Sphingomyelin Metabolism","7.75E-01","1.25E-01","NaN","SMPD1"]
["Hepatic Fibrosis Signaling Pathway","7.69E-01","3.07E-02",-1.155,"BAMBI,CACNG2,CCND1,CREB5,CXCL8,EDN1,IL18,LEF1,MYL9,NCF1,PRKAR1B,SPP1,TCF7"]
["Endocannabinoid Developing Neuron Pathway","7.68E-01","3.88E-02",-1,"CCND1,CNR2,CREB5,PRKAR1B,RAP1GAP"]
["Protein Ubiquitination Pathway","7.68E-01","3.3E-02","NaN","HLA-A,HSPA1A/HSPA1B,HSPA6,HSPB1,PSMB9,PSME2,TAP1,UBE2L6,UCHL1"]
["Signal amplification","7.65E-01","6.06E-02","NaN","GNA15,GNG8"]
["Cardiac Hypertrophy Signaling (Enhanced)","7.51E-01","2.94E-02",-1.155,"CACNG2,CLCF1,CXCL8,EDN1,FGFRL1,GNA15,HSPB1,IL18,IL7R,INPP5F,PDE7B,PDE9A,PLCL1,PRKAR1B,TNFSF10,TNFSF13B"]
["Mitochondrial biogenesis","7.5E-01","4.69E-02","NaN","ALAS1,CAMK4,SMARCD3"]
["Signaling by NOTCH2","7.44E-01","5.88E-02","NaN","NEURL1,PSENEN"]
["Pyridoxal 5'-phosphate Salvage Pathway","7.37E-01","4.62E-02","NaN","CDK1,LIMK2,PLK1"]
["Urea cycle","7.29E-01","1.11E-01","NaN","ARG1"]
["Interleukin-9 signaling","7.29E-01","1.11E-01","NaN","STAT1"]
["Prednisone ADME","7.29E-01","1.11E-01","NaN","ALB"]
["Sucrose Degradation V (Mammalian)","7.29E-01","1.11E-01","NaN","ALDOA"]
["Folate Transformations I","7.29E-01","1.11E-01","NaN","MTHFD2L"]
["Androgen Signaling","7.27E-01","3.55E-02","NaN","CACNG2,CCND1,GNA15,H3C3,PRKAR1B,TGFB1I1"]
["Metabolism of steroid hormones","7.25E-01","5.71E-02","NaN","POMC,TSPO"]
["Coagulation System","7.25E-01","5.71E-02","NaN","FGA,FGB"]
["Ethanol Degradation II","7.25E-01","5.71E-02","NaN","ALDH1A1,DHRS9"]
["RHO GTPases Activate WASPs and WAVEs","7.06E-01","5.56E-02","NaN","ARPC1B,WASF1"]
["IL-9 Signaling","7.06E-01","5.56E-02","NaN","SOCS3,STAT1"]
["Clathrin-mediated Endocytosis Signaling","7.02E-01","3.35E-02","NaN","ALB,APOA4,ARPC1B,CLTCL1,LYZ,ORM1,S100A8"]
["Role of Tissue Factor in Cancer","7.02E-01","3.35E-02",0.378,"BIRC5,CXCL8,FGA,FGB,GNA15,LIMK2,ZEB1"]
["3-phosphoinositide Biosynthesis","7.02E-01","3.35E-02",0,"ALPL,CDC25A,INPP5F,MINPP1,NOCT,PLPP6,SOCS3"]
["TNFR2 non-canonical NF-kB pathway","6.97E-01","4.41E-02","NaN","PSMB9,PSME2,TNFSF13B"]
["Glioblastoma Multiforme Signaling","6.96E-01","3.47E-02",-2,"CCND1,E2F1,E2F8,IGF2,LEF1,PLCL1"]
["Phase I - Functionalization of compounds","6.95E-01","3.92E-02",2,"ALDH1A1,CYB5R3,CYP2C8,POMC"]
["Aldosterone Signaling in Epithelial Cells","6.89E-01","3.45E-02","NaN","HSPA1A/HSPA1B,HSPA6,HSPB1,KCNMA1,NR3C2,PLCL1"]
["Gene and protein expression by JAK-STAT signaling after IL-12 stimulation","6.88E-01","5.41E-02","NaN","LMNB1,PSME2"]
["Noradrenaline and Adrenaline Degradation","6.88E-01","5.41E-02","NaN","ALDH1A1,DHRS9"]
["Calcium Transport I","6.88E-01","1E-01","NaN","ATP2B1"]
["Citrulline Biosynthesis","6.88E-01","1E-01","NaN","ARG1"]
["Phospholipases","6.85E-01","4.35E-02","NaN","LPL,PLB1,PLCL1"]
["Superpathway of Melatonin Degradation","6.85E-01","4.35E-02","NaN","CYP2C8,MPO,SULT1A2"]
["Integration of energy metabolism","6.85E-01","3.88E-02","NaN","GNA15,GNG8,PRKAR1B,SLC2A1"]
["Neuropathic Pain Signaling in Dorsal Horn Neurons","6.85E-01","3.88E-02",0,"CAMK4,GRIN3A,PLCL1,PRKAR1B"]
["Adipogenesis pathway","6.79E-01","3.6E-02",0.447,"FGFRL1,KLF5,LPL,NOCT,TCF7"]
["Th2 Pathway","6.79E-01","3.6E-02",1.342,"GFI1,HLA-A,PSENEN,PTGDR2,SOCS3"]
["Fanconi Anemia Pathway","6.71E-01","5.26E-02","NaN","EME1,EME2"]
["Notch Signaling","6.71E-01","5.26E-02","NaN","HEY2,PSENEN"]
["Pulmonary Fibrosis Idiopathic Signaling Pathway","6.69E-01","3.05E-02",-1.265,"BIRC5,CCND1,COL17A1,EDN1,FGFRL1,LEF1,MMP8,SFTPA2,SFTPC,TCF7"]
["Wound Healing Signaling Pathway","6.66E-01","3.17E-02",1.414,"CLCF1,COL17A1,CXCL8,IL18,MMP8,STAT1,TNFSF10,TNFSF13B"]
["Erythropoietin Signaling Pathway","6.59E-01","3.37E-02",-0.816,"CCND1,CLCF1,CXCL8,IL18,TNFSF10,TNFSF13B"]
["IGF-1 Signaling","6.56E-01","3.77E-02","NaN","IGFBP5,PRKAR1B,SOCS1,SOCS3"]
["Regulation of TP53 Expression and Degradation","6.54E-01","5.13E-02","NaN","CCNA2,CDK1"]
["Erythrocytes take up carbon dioxide and release oxygen","6.51E-01","9.09E-02","NaN","RHAG"]
["Signaling by Leptin","6.51E-01","9.09E-02","NaN","SOCS3"]
["Metallothioneins bind metals","6.51E-01","9.09E-02","NaN","MT1X"]
["Glycogen Degradation II","6.51E-01","9.09E-02","NaN","TYMP"]
["Protein Kinase A Signaling","6.44E-01","2.92E-02",-0.333,"CDC25A,CREB5,H1-5,H3C3,LEF1,MYL9,PDE7B,PDE9A,PLCL1,PRKAR1B,PTPRU,TCF7"]
["Transcriptional Regulation by VENTX","6.38E-01","5E-02","NaN","CCND1,LEF1"]
["Pyrimidine Ribonucleotides Interconversion","6.38E-01","5E-02","NaN","ENTPD7,NME4"]
["Regulation of RUNX2 expression and activity","6.38E-01","4.11E-02","NaN","PSMB9,PSME2,STAT1"]
["Extra-nuclear estrogen signaling","6.38E-01","4.11E-02","NaN","CCND1,GNG8,HSPB1"]
["Serotonin Degradation","6.38E-01","4.11E-02","NaN","ALDH1A1,DHRS9,SULT1A2"]
["LPS/IL-1 Mediated Inhibition of RXR Function","6.36E-01","3.11E-02","NaN","ABCB11,ALAS1,ALDH1A1,CETP,CYP2C8,GSTM5,IL18,SULT1A2"]
["DAG and IP3 signaling","6.23E-01","4.88E-02","NaN","CAMK4,PRKAR1B"]
["Activation of gene expression by SREBF (SREBP)","6.23E-01","4.88E-02","NaN","MVK,SMARCD3"]
["Presynaptic depolarization and calcium channel opening","6.18E-01","8.33E-02","NaN","CACNG2"]
["Peptide hormone biosynthesis","6.18E-01","8.33E-02","NaN","POMC"]
["Œ≥-glutamyl Cycle","6.18E-01","8.33E-02","NaN","GGT7"]
["GPCR-Mediated Integration of Enteroendocrine Signaling Exemplified by an L Cell","6.15E-01","4E-02","NaN","GNA15,PLCL1,PRKAR1B"]
["O-linked glycosylation","6.1E-01","3.6E-02",2,"B4GALT5,GALNT14,MUC3A,ST3GAL4"]
["Intrinsic Prothrombin Activation Pathway","6.07E-01","4.76E-02","NaN","FGA,FGB"]
["Hypoxia Signaling in the Cardiovascular System","6.05E-01","3.95E-02","NaN","CREB5,EDN1,UBE2L6"]
["Binding and Uptake of Ligands by Scavenger Receptors","6.02E-01","3.57E-02",1,"ALB,MSR1,SAA1,SPARC"]
["NAFLD Signaling Pathway","5.93E-01","3.1E-02",1.134,"CLCF1,CXCL8,IL18,SOCS1,SOCS3,TNFSF10,TNFSF13B"]
["Dilated Cardiomyopathy Signaling Pathway","5.93E-01","3.33E-02",0,"CACNG2,CAMK4,MYL9,PRKAR1B,TNNT3"]
["Defensins","5.93E-01","4.65E-02","NaN","DEFA1 (includes others),DEFA4"]
["Vasopressin regulates renal water homeostasis via Aquaporins","5.93E-01","4.65E-02","NaN","GNG8,PRKAR1B"]
["Smooth Muscle Contraction","5.93E-01","4.65E-02","NaN","DYSF,MYL9"]
["B Cell Activating Factor Signaling","5.93E-01","4.65E-02","NaN","TNFRSF13B,TNFSF13B"]
["Retinoate Biosynthesis I","5.93E-01","4.65E-02","NaN","ALDH1A1,DHRS9"]
["Pyrimidine Ribonucleotides De Novo Biosynthesis","5.93E-01","4.65E-02","NaN","ENTPD7,NME4"]
["POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation","5.88E-01","7.69E-02","NaN","EPHA1"]
["Passive transport by Aquaporins","5.88E-01","7.69E-02","NaN","AQP9"]
["Mitotic Telophase/Cytokinesis","5.88E-01","7.69E-02","NaN","PLK1"]
["Azathioprine ADME","5.88E-01","7.69E-02","NaN","SLC28A3"]
["Glycogen Degradation III","5.88E-01","7.69E-02","NaN","TYMP"]
["UDP-N-acetyl-D-galactosamine Biosynthesis II","5.88E-01","7.69E-02","NaN","GPI"]
["Signaling by NOTCH1","5.84E-01","3.85E-02","NaN","HEY2,NEURL1,PSENEN"]
["Costimulation by the CD28 family","5.84E-01","3.85E-02","NaN","CD274,PDCD1LG2,TRAC"]
["Elastic fibre formation","5.79E-01","4.55E-02","NaN","FBLN5,LTBP3"]
["TAK1-dependent IKK and NF-kappa-B activation","5.79E-01","4.55E-02","NaN","S100A12,SAA1"]
["Regulation of mRNA stability by proteins that bind AU-rich elements","5.79E-01","4.55E-02","NaN","HSPA1A/HSPA1B,HSPB1"]
["Signaling by Retinoic Acid","5.79E-01","4.55E-02","NaN","ALDH1A1,DHRS9"]
["BER (Base Excision Repair) Pathway","5.79E-01","4.55E-02","NaN","E2F1,NTHL1"]
["DDX58/IFIH1-mediated induction of interferon-alpha/beta","5.74E-01","3.8E-02","NaN","S100A12,SAA1,UBE2L6"]
["Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza","5.74E-01","3.8E-02","NaN","CXCL10,CXCL8,PLB1"]
["Type II Diabetes Mellitus Signaling","5.72E-01","3.27E-02","NaN","CACNG2,PKM,SMPD1,SOCS1,SOCS3"]
["Signaling by Rho Family GTPases","5.71E-01","2.97E-02",1.633,"ARPC1B,CDH5,CIT,GNA15,LIMK2,MYL9,NCF1,WASF1"]
["Signaling by ROBO receptors","5.68E-01","3.45E-02",0,"ENAH,NELL2,PSMB9,PSME2"]
["Prostate Cancer Signaling","5.68E-01","3.45E-02","NaN","CCND1,CREB5,E2F1,LEF1"]
["Bladder Cancer Signaling","5.68E-01","3.45E-02","NaN","CCND1,CXCL8,E2F1,MMP8"]
["Arachidonic acid metabolism","5.65E-01","4.44E-02","NaN","CYP2C8,GPX1"]
["GPER1 signaling","5.65E-01","4.44E-02","NaN","GNG8,PRKAR1B"]
["Coronavirus Replication Pathway","5.65E-01","4.44E-02","NaN","IFITM2,IFITM3"]
["Glycosaminoglycan metabolism","5.64E-01","3.75E-02","NaN","B4GALT5,SDC3,ST3GAL4"]
["DNA Double-Strand Break Repair by Homologous Recombination","5.61E-01","7.14E-02","NaN","RAD51"]
["Acyl-CoA Hydrolysis","5.61E-01","7.14E-02","NaN","ACOT7"]
["Leukotriene Biosynthesis","5.61E-01","7.14E-02","NaN","GGT7"]
["Mevalonate Pathway I","5.61E-01","7.14E-02","NaN","MVK"]
["Colanic Acid Building Blocks Biosynthesis","5.61E-01","7.14E-02","NaN","GPI"]
["Serotonin Receptor Signaling","5.6E-01","2.76E-02",1.387,"CACNG2,CREB5,CXCL8,EDN1,FFAR2,FGA,FGB,GNA15,H3C3,ORAI3,PLB1,PLCL1,PRKAR1B"]
["IL-13 Signaling Pathway","5.52E-01","3.39E-02",0,"ARG1,SOCS1,SOCS3,STAT1"]
["Interleukin-2 family signaling","5.52E-01","4.35E-02","NaN","INPP5F,STAT1"]
["tRNA Splicing","5.52E-01","4.35E-02","NaN","PDE7B,PDE9A"]
["Colorectal Cancer Metastasis Signaling","5.5E-01","2.93E-02",0.816,"BIRC5,CCND1,GNA15,LEF1,MMP8,PRKAR1B,STAT1,TCF7"]
["Synthesis of DNA","5.45E-01","3.36E-02",2,"CCNA2,GINS2,PSMB9,PSME2"]
["Fcgamma receptor (FCGR) dependent phagocytosis","5.44E-01","3.18E-02",2.236,"ARPC1B,FCGR1A,FCGR2A,FCGR3A/FCGR3B,WASF1"]
["iNOS Signaling","5.39E-01","4.26E-02","NaN","IRF1,STAT1"]
["nNOS Signaling in Neurons","5.39E-01","4.26E-02","NaN","DLG4,GRIN3A"]
["Apelin Pancreas Signaling Pathway","5.39E-01","4.26E-02","NaN","APLNR,PRKAR1B"]
["eNOS Signaling","5.38E-01","3.16E-02","NaN","AQP9,CCNA2,HSPA1A/HSPA1B,HSPA6,PRKAR1B"]
["Epithelial Adherens Junction Signaling","5.38E-01","3.16E-02",2.236,"ARPC1B,LEF1,LIMK2,TCF7,WASF1"]
["Regulation of the Epithelial-Mesenchymal Transition Pathway","5.36E-01","3.05E-02","NaN","FGFRL1,HMGA2,LEF1,PSENEN,TCF7,ZEB1"]
["Mismatch Repair","5.35E-01","6.67E-02","NaN","EXO1"]
["Platelet Adhesion to exposed collagen","5.35E-01","6.67E-02","NaN","FCER1G"]
["Insulin Secretion Signaling Pathway","5.35E-01","2.9E-02",1.134,"CACNG2,CREB5,GNA15,PLCL1,PRKAR1B,SLC2A1,SLC2A5,STAT1"]
["Superpathway of Inositol Phosphate Compounds","5.32E-01","2.95E-02",0,"ALPL,CDC25A,INPP5F,MINPP1,NOCT,PLPP6,SOCS3"]
["Apelin Muscle Signaling Pathway","5.26E-01","4.17E-02","NaN","APLNR,GNA15"]
["IL-23 Signaling Pathway","5.26E-01","4.17E-02","NaN","IL23A,SOCS3"]
["Activation of NMDA receptors and postsynaptic events","5.26E-01","3.57E-02","NaN","CAMK4,DLG4,PRKAR1B"]
["JAK/STAT Signaling","5.26E-01","3.57E-02","NaN","SOCS1,SOCS3,STAT1"]
["Pulmonary Healing Signaling Pathway","5.25E-01","3.02E-02",0,"CCND1,ELANE,FOXM1,LEF1,MMP8,TCF7"]
["Sphingosine-1-phosphate Signaling","5.22E-01","3.28E-02",0,"CASP5,PLCL1,S1PR2,SMPD1"]
["Rap1 signalling","5.12E-01","6.25E-02","NaN","RAP1GAP"]
["Granzyme B Signaling","5.12E-01","6.25E-02","NaN","LMNB1"]
["Superpathway of Citrulline Metabolism","5.12E-01","6.25E-02","NaN","ARG1"]
["D-myo-inositol (1,4,5)-trisphosphate Degradation","5.12E-01","6.25E-02","NaN","INPP5F"]
["Parkinson's Signaling","5.12E-01","6.25E-02","NaN","UCHL1"]
["PEDF Signaling","5.08E-01","3.49E-02","NaN","SERPINF1,TCF7,ZEB1"]
["Gustation Pathway","5.08E-01","2.97E-02",0.816,"CACNG2,LPL,P2RY13,P2RY14,P2RY6,PRKAR1B"]
["Ephrin Receptor Signaling","5.08E-01","2.97E-02",2.236,"ARPC1B,CREB5,EPHA1,GNA15,GRIN3A,LIMK2"]
["Signaling by FGFR1","5.02E-01","4E-02","NaN","FGFRL1,FLRT2"]
["Regulation of the Epithelial Mesenchymal Transition in Development Pathway","5E-01","3.45E-02","NaN","LEF1,PSENEN,TCF7"]
["Oxytocin Signaling Pathway","4.97E-01","2.82E-02",0.707,"ATP2B1,CACNG2,CREB5,CXCL8,HSPB1,LPL,MYL9,PRKAR1B"]
["TCR signaling","4.93E-01","3.17E-02",0,"ENAH,PSMB9,PSME2,TRAC"]
["Amyloid Processing","4.91E-01","3.92E-02","NaN","PRKAR1B,PSENEN"]
["Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","4.9E-01","5.88E-02","NaN","IGF2"]
["1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian)","4.9E-01","5.88E-02","NaN","INPP5F"]
["Dermatan Sulfate Degradation (Metazoa)","4.9E-01","5.88E-02","NaN","FGFRL1"]
["Neddylation","4.86E-01","2.85E-02",1.134,"BIRC5,FBXO6,FBXO7,KBTBD8,PSMB9,PSME2,SOCS3"]
["Apoptotic execution phase","4.8E-01","3.85E-02","NaN","H1-5,LMNB1"]
["Melanoma Signaling","4.8E-01","3.85E-02","NaN","CCND1,E2F1"]
["Estrogen Receptor Signaling","4.78E-01","2.68E-02",1.265,"CACNG2,CCND1,CREB5,DLG4,GNA15,IGF2,LIMK2,MMP8,MYL9,PLCL1,PRKAR1B"]
["Regulation of Cellular Mechanics by Calpain Protease","4.75E-01","3.33E-02","NaN","CCNA2,CCND1,CDK1"]
["Unfolded protein response","4.75E-01","3.33E-02","NaN","CEBPE,HSPA1A/HSPA1B,HSPA6"]
["GP6 Signaling Pathway","4.73E-01","3.1E-02",2,"COL17A1,FCER1G,FGA,FGB"]
["RORA activates gene expression","4.7E-01","5.56E-02","NaN","SMARCD3"]
["Nicotinate metabolism","4.7E-01","5.56E-02","NaN","NNMT"]
["Mismatch Repair in Eukaryotes","4.7E-01","5.56E-02","NaN","EXO1"]
["Superpathway of Geranylgeranyldiphosphate Biosynthesis I (via Mevalonate)","4.7E-01","5.56E-02","NaN","MVK"]
["HMGB1 Signaling","4.7E-01","2.96E-02","NaN","CLCF1,CXCL8,IL18,TNFSF10,TNFSF13B"]
["Signaling by TGF-beta Receptor Complex","4.69E-01","3.77E-02","NaN","BAMBI,LTBP3"]
["Factors involved in megakaryocyte development and platelet production","4.67E-01","3.3E-02","NaN","IRF1,MYB,PRKAR1B"]
["Crosstalk between Dendritic Cells and Natural Killer Cells","4.67E-01","3.3E-02","NaN","HLA-A,IL18,TNFSF10"]
["BMP signaling pathway","4.67E-01","3.3E-02","NaN","CAMK4,GREM1,PRKAR1B"]
["Ferroptosis Signaling Pathway","4.6E-01","3.05E-02",-1,"H2AX,H2BC17,HSPB1,SLC39A8"]
["Metabolism of cofactors","4.51E-01","5.26E-02","NaN","DHFR"]
["Œ≥-linolenate Biosynthesis II (Animals)","4.51E-01","5.26E-02","NaN","CYB5R3"]
["Ceramide Signaling","4.51E-01","3.23E-02","NaN","CTSD,S1PR2,SMPD1"]
["Acute Myeloid Leukemia Signaling","4.51E-01","3.23E-02","NaN","CCND1,LEF1,TCF7"]
["HSP90 chaperone cycle for steroid hormone receptors in the presence of ligand","4.49E-01","3.64E-02","NaN","HSPA1A/HSPA1B,NR3C2"]
["Signaling by PTK6","4.49E-01","3.64E-02","NaN","CCND1,SOCS3"]
["fMLP Signaling in Neutrophils","4.47E-01","3.01E-02","NaN","ARPC1B,FPR1,GNA15,NCF1"]
["WNT/Œ≤-catenin Signaling","4.42E-01","2.87E-02","NaN","CCND1,CDH5,KREMEN1,LEF1,TCF7"]
["NLR signaling pathways","4.39E-01","3.57E-02","NaN","AIM2,NLRC4"]
["Triacylglycerol Biosynthesis","4.39E-01","3.57E-02","NaN","AGPAT1,PLPP6"]
["Oxidative Ethanol Degradation III","4.39E-01","3.57E-02","NaN","ALDH1A1,CYP2C8"]
["Netrin Signaling","4.37E-01","2.86E-02",0.447,"ARPC1B,CACNG2,DPYSL3,ENAH,PRKAR1B"]
["P2Y Purigenic Receptor Signaling Pathway","4.35E-01","2.96E-02",1,"CREB5,P2RY6,PLCL1,PRKAR1B"]
["STAT3 Pathway","4.35E-01","2.96E-02","NaN","CDC25A,IL7R,SOCS1,SOCS3"]
["Neurexins and neuroligins","4.29E-01","3.51E-02","NaN","DLG4,LIN7A"]
["FAT10 Signaling Pathway","4.29E-01","3.51E-02","NaN","PSMB9,PSME2"]
["Death Receptor Signaling","4.29E-01","3.12E-02","NaN","HSPB1,TNFRSF10A,TNFSF10"]
["Cellular response to heat stress","4.22E-01","3.09E-02","NaN","HSPA1A/HSPA1B,HSPA6,HSPB1"]
["Activin Inhibin Signaling Pathway","4.21E-01","2.74E-02",0,"BAMBI,IL18,LEF1,LIMK2,TCF7,TNFSF13B"]
["Signaling by PDGF","4.2E-01","3.45E-02","NaN","SPP1,STAT1"]
["RHO GTPases activate PAKs","4.17E-01","4.76E-02","NaN","MYL9"]
["Synaptic adhesion-like molecules","4.17E-01","4.76E-02","NaN","DLG4"]
["Digestion","4.17E-01","4.76E-02","NaN","CHIT1"]
["Histamine Degradation","4.17E-01","4.76E-02","NaN","ALDH1A1"]
["Fatty Acid Œ±-oxidation","4.17E-01","4.76E-02","NaN","ALDH1A1"]
["RHOGDI Signaling","4.17E-01","2.73E-02",-1.342,"ARPC1B,CDH5,GNA15,LIMK2,MYL9,WASF1"]
["Protein folding","4.15E-01","3.06E-02","NaN","FBXO6,GNA15,GNG8"]
["RAC Signaling","4.11E-01","2.88E-02","NaN","ARPC1B,LIMK2,NCF1,WASF1"]
["Cardiac Œ≤-adrenergic Signaling","4.11E-01","2.78E-02","NaN","CACNG2,GNA15,PDE7B,PDE9A,PRKAR1B"]
["Metabolism of polyamines","4.1E-01","3.39E-02","NaN","PSMB9,PSME2"]
["Reelin Signaling in Neurons","4.05E-01","2.86E-02",1,"ARPC1B,CNR2,GRIN3A,WASF1"]
["Visual phototransduction","4.02E-01","3.33E-02","NaN","DHRS9,TTR"]
["NIK-->noncanonical NF-kB signaling","4.02E-01","3.33E-02","NaN","PSMB9,PSME2"]
["SPINK1 Pancreatic Cancer Pathway","4.02E-01","3.33E-02","NaN","CPA4,ELANE"]
["Putrescine Degradation III","4.01E-01","4.55E-02","NaN","ALDH1A1"]
["Melanocyte Development and Pigmentation Signaling","4.01E-01","3E-02","NaN","CREB5,POMC,PRKAR1B"]
["UVA-Induced MAPK Signaling","4.01E-01","3E-02","NaN","PLCL1,SMPD1,STAT1"]
["Role of Chondrocytes in Rheumatoid Arthritis Signaling Pathway","4E-01","2.84E-02",1,"CEBPE,CXCL8,IL18,MMP8"]
["ABC-family proteins mediated transport","3.94E-01","2.97E-02","NaN","ABCD2,PSMB9,PSME2"]
["Apelin Cardiomyocyte Signaling Pathway","3.94E-01","2.97E-02","NaN","APLNR,MYL9,PLCL1"]
["MSP-RON Signaling in Cancer Cells Pathway","3.94E-01","2.82E-02",-1,"CCND1,CREB5,LEF1,TCF7"]
["Assembly of collagen fibrils and other multimeric structures","3.93E-01","3.28E-02","NaN","CD151,COL17A1"]
["Circadian Rhythm Signaling","3.9E-01","2.61E-02","NaN","CACNG2,CREB5,GNA15,GRIN3A,H3C3,PLCL1,PRKAR1B"]
["Beta-catenin independent WNT signaling","3.88E-01","2.94E-02","NaN","GNG8,LEF1,TCF7"]
["RAF-independent MAPK1/3 activation","3.87E-01","4.35E-02","NaN","CDK1"]
["Formation of paraxial mesoderm","3.87E-01","4.35E-02","NaN","LEF1"]
["Apelin Cardiac Fibroblast Signaling Pathway","3.87E-01","4.35E-02","NaN","APLNR"]
["Cytoprotection by HMOX1","3.84E-01","3.23E-02","NaN","ALB,SMARCD3"]
["Endometrial Cancer Signaling","3.84E-01","3.23E-02","NaN","CCND1,LEF1"]
["Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis","3.73E-01","2.61E-02","NaN","ALPL,IL18,LEF1,MMP8,SPP1,TCF7"]
["Sulfur amino acid metabolism","3.73E-01","4.17E-02","NaN","SQOR"]
["Other interleukin signaling","3.73E-01","4.17E-02","NaN","PRTN3"]
["The Visual Cycle","3.73E-01","4.17E-02","NaN","DHRS9"]
["Melatonin Degradation I","3.68E-01","3.12E-02","NaN","CYP2C8,SULT1A2"]
["IL-17 Signaling","3.68E-01","2.65E-02",0.447,"CLCF1,CXCL8,IL18,TNFSF10,TNFSF13B"]
["Synaptogenesis Signaling Pathway","3.65E-01","2.52E-02",2.121,"ARPC1B,CDH5,CREB5,DLG4,EPHA1,GRIN3A,PRKAR1B,WASF1"]
["Macroautophagy","3.6E-01","3.08E-02","NaN","MAP1LC3A,RRAGD"]
["Hedgehog ligand biogenesis","3.6E-01","3.08E-02","NaN","PSMB9,PSME2"]
["RAB geranylgeranylation","3.6E-01","3.08E-02","NaN","RAB20,RAB39A"]
["Activation of IRF by Cytosolic Pattern Recognition Receptors","3.6E-01","3.08E-02","NaN","IFIT2,STAT1"]
["Cholesterol biosynthesis","3.6E-01","4E-02","NaN","PLPP6"]
["Bupropion Degradation","3.6E-01","4E-02","NaN","CYP2C8"]
["Ethanol Degradation IV","3.6E-01","4E-02","NaN","ALDH1A1"]
["WNT/Ca+ pathway","3.53E-01","3.03E-02","NaN","CREB5,PLCL1"]
["Glutamate Receptor Signaling","3.53E-01","3.03E-02","NaN","DLG4,GRIN3A"]
["Cellular Effects of Sildenafil (Viagra)","3.52E-01","2.67E-02","NaN","CACNG2,MYL9,PLCL1,PRKAR1B"]
["PPARŒ±/RXRŒ± Activation","3.46E-01","2.58E-02","NaN","CYP2C8,GNA15,LPL,PLCL1,PRKAR1B"]
["Regulation of the Epithelial Mesenchymal Transition by Growth Factors Pathway","3.46E-01","2.58E-02",0.447,"FGFRL1,HMGA2,TNFSF10,TNFSF13B,ZEB1"]
["Œ±-Adrenergic Signaling","3.45E-01","2.75E-02","NaN","CAMK4,GNA15,PRKAR1B"]
["PD-1, PD-L1 cancer immunotherapy pathway","3.45E-01","2.75E-02","NaN","CD274,HLA-A,PDCD1LG2"]
["Phase II - Conjugation of compounds","3.45E-01","2.99E-02","NaN","GGT7,NNMT"]
["Semaphorin Neuronal Repulsive Signaling Pathway","3.43E-01","2.63E-02",1,"DPYSL3,LIMK2,MYL9,PRKAR1B"]
["Xenobiotic Metabolism PXR Signaling Pathway","3.42E-01","2.56E-02",1.342,"ALDH1A1,CYP2C8,GSTM5,PRKAR1B,SULT1A2"]
["Glucocorticoid Receptor Signaling","3.41E-01","2.4E-02","NaN","CXCL8,FCGR1A,H3C3,HLA-A,HSPA1A/HSPA1B,HSPA6,IL7R,KRT1,MMP8,NR3C2,POMC,SLPI,SMARCD3,STAT1"]
["Endothelin-1 Signaling","3.38E-01","2.55E-02",0.447,"CASP5,EDN1,GNA15,PLB1,PLCL1"]
["Syndecan interactions","3.35E-01","3.7E-02","NaN","SDC3"]
["ATF4 activates genes in response to endoplasmic reticulum stress","3.35E-01","3.7E-02","NaN","CXCL8"]
["Tryptophan Degradation X (Mammalian, via Tryptamine)","3.35E-01","3.7E-02","NaN","ALDH1A1"]
["Sensory processing of sound by inner hair cells of the cochlea","3.31E-01","2.9E-02","NaN","ATP2B1,KCNMA1"]
["Myelination Signaling Pathway","3.29E-01","2.44E-02",0,"CREB5,FGFRL1,LMNB1,MPZ,OLIG1,PRKAR1B,PSENEN,SLC2A1"]
["Hedgehog 'off' state","3.29E-01","2.68E-02","NaN","PRKAR1B,PSMB9,PSME2"]
["Necroptosis Signaling Pathway","3.29E-01","2.58E-02",1,"STAT1,TNFRSF10A,TNFSF10,TSPO"]
["MTOR signalling","3.24E-01","3.57E-02","NaN","RRAGD"]
["Signaling by ALK","3.24E-01","3.57E-02","NaN","CD274"]
["Glyoxylate metabolism and glycine degradation","3.24E-01","3.57E-02","NaN","PXMP2"]
["RHO GTPases activate PKNs","3.24E-01","3.57E-02","NaN","MYL9"]
["Glutathione Redox Reactions I","3.24E-01","3.57E-02","NaN","GPX1"]
["CDP-diacylglycerol Biosynthesis I","3.24E-01","3.57E-02","NaN","AGPAT1"]
["Relaxin Signaling","3.2E-01","2.55E-02","NaN","GNA15,PDE7B,PDE9A,PRKAR1B"]
["ISG15 antiviral mechanism","3.17E-01","2.82E-02","NaN","STAT1,UBE2L6"]
["ILK Signaling","3.13E-01","2.48E-02",0.447,"CCND1,CREB5,LEF1,MYL9,TGFB1I1"]
["Regulation of Actin-based Motility by Rho","3.13E-01","2.61E-02","NaN","ARPC1B,MYL9,WASF1"]
["Energy dependent regulation of mTOR by LKB1-AMPK","3.13E-01","3.45E-02","NaN","RRAGD"]
["EGR2 and SOX10-mediated initiation of Schwann cell myelination","3.13E-01","3.45E-02","NaN","MPZ"]
["Superpathway of Cholesterol Biosynthesis","3.13E-01","3.45E-02","NaN","MVK"]
["Melatonin Signaling","3.11E-01","2.78E-02","NaN","PLCL1,PRKAR1B"]
["Basal Cell Carcinoma Signaling","3.11E-01","2.78E-02","NaN","LEF1,TCF7"]
["GM-CSF Signaling","3.11E-01","2.78E-02","NaN","CCND1,STAT1"]
["Microautophagy Signaling Pathway","3.07E-01","2.5E-02","NaN","COL17A1,MAP1LC3A,PSMB9,PSME2"]
["Coronavirus Pathogenesis Pathway","3.06E-01","2.45E-02",-1.342,"CCND1,CXCL8,E2F1,E2F8,STAT1"]
["Mitophagy","3.03E-01","3.33E-02","NaN","MAP1LC3A"]
["Phosphatidylglycerol Biosynthesis II (Non-plastidic)","3.03E-01","3.33E-02","NaN","AGPAT1"]
["Amyotrophic Lateral Sclerosis Signaling","2.98E-01","2.54E-02","NaN","CACNG2,GPX1,GRIN3A"]
["Bile acid and bile salt metabolism","2.93E-01","3.23E-02","NaN","ABCB11"]
["Signaling by CSF1 (M-CSF) in myeloid cells","2.93E-01","3.23E-02","NaN","STAT1"]
["Cellular response to hypoxia","2.92E-01","2.67E-02","NaN","PSMB9,PSME2"]
["Caveolar-mediated Endocytosis Signaling","2.92E-01","2.67E-02","NaN","ALB,HLA-A"]
["Granzyme A Signaling","2.92E-01","2.67E-02","NaN","H1-5,LMNB1"]
["Fc Epsilon RI Signaling","2.88E-01","2.5E-02","NaN","FCER1A,FCER1G,INPP5F"]
["G-protein beta:gamma signalling","2.83E-01","3.12E-02","NaN","GNG8"]
["Role of p14/p19ARF in Tumor Suppression","2.83E-01","3.12E-02","NaN","E2F1"]
["IL-15 Production","2.75E-01","2.44E-02","NaN","EPHA1,IRF1,STAT1"]
["Role of WNT/GSK-3Œ≤ Signaling in the Pathogenesis of Influenza","2.74E-01","2.56E-02","NaN","LEF1,TCF7"]
["Mitochondrial Dysfunction","2.74E-01","2.31E-02",0,"CACNG2,COX7A1,CREB5,CYB5R3,GPX1,OPA1,PRKAR1B,PSENEN"]
["Gap junction trafficking and regulation","2.66E-01","2.94E-02","NaN","CLTCL1"]
["Oncogene Induced Senescence","2.66E-01","2.94E-02","NaN","E2F1"]
["GŒ±s Signaling","2.61E-01","2.38E-02","NaN","CREB5,GNA15,PRKAR1B"]
["Cardiac Hypertrophy Signaling","2.61E-01","2.29E-02",1.342,"CACNG2,GNA15,HSPB1,MYL9,PLCL1,PRKAR1B"]
["ERK/MAPK Signaling","2.6E-01","2.3E-02",2.236,"CREB5,H3C3,HSPB1,PRKAR1B,STAT1"]
["Chemokine Signaling","2.58E-01","2.47E-02","NaN","CAMK4,LIMK2"]
["GPVI-mediated activation cascade","2.58E-01","2.86E-02","NaN","FCER1G"]
["Interleukin-1 family signaling","2.53E-01","2.34E-02","NaN","IL18,PSMB9,PSME2"]
["Striated Muscle Contraction","2.5E-01","2.78E-02","NaN","TNNT3"]
["Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","2.5E-01","2.78E-02","NaN","CITED4"]
["G Beta Gamma Signaling","2.49E-01","2.33E-02","NaN","CACNG2,GNA15,PRKAR1B"]
["Transport of bile salts and organic acids, metal ions and amine compounds","2.48E-01","2.41E-02","NaN","RHAG,SLC39A8"]
["RNA polymerase II transcribes snRNA genes","2.48E-01","2.41E-02","NaN","RNU5A-1,RNU5B-1"]
["Heparan Sulfate Biosynthesis (Late Stages)","2.48E-01","2.41E-02","NaN","SULT1A2,TNFAIP6"]
["Cardiac conduction","2.45E-01","2.31E-02","NaN","ATP2B1,CORIN,KCNJ2"]
["FLT3 Signaling in Hematopoietic Progenitor Cells","2.43E-01","2.38E-02","NaN","CREB5,STAT1"]
["Estrogen-Dependent Breast Cancer Signaling","2.43E-01","2.38E-02","NaN","CCND1,CREB5"]
["Role of MAPK Signaling in the Pathogenesis of Influenza","2.43E-01","2.38E-02","NaN","CXCL10,PLB1"]
["Resolution of Abasic Sites (AP sites)","2.35E-01","2.63E-02","NaN","NTHL1"]
["Glutathione-mediated Detoxification","2.35E-01","2.63E-02","NaN","GSTM5"]
["Hedgehog 'on' state","2.33E-01","2.33E-02","NaN","PSMB9,PSME2"]
["Xenobiotic Metabolism AHR Signaling Pathway","2.29E-01","2.3E-02","NaN","ALDH1A1,GSTM5"]
["NGF-stimulated transcription","2.28E-01","2.56E-02","NaN","EGR3"]
["tRNA Charging","2.28E-01","2.56E-02","NaN","WARS1"]
["Inhibition of Matrix Metalloproteases","2.28E-01","2.56E-02","NaN","MMP8"]
["TP53 Regulates Metabolic Genes","2.24E-01","2.27E-02","NaN","GPI,RRAGD"]
["FGF Signaling","2.24E-01","2.27E-02","NaN","CREB5,FGFRL1"]
["Neurotransmitter release cycle","2.21E-01","2.5E-02","NaN","LIN7A"]
["Transport of vitamins, nucleosides, and related molecules","2.14E-01","2.44E-02","NaN","SLC28A3"]
["RET signaling","2.14E-01","2.44E-02","NaN","RAP1GAP"]
["Mechanisms of Viral Exit from Host Cells","2.14E-01","2.44E-02","NaN","LMNB1"]
["DAP12 interactions","2.08E-01","2.38E-02","NaN","CLEC5A"]
["April Mediated Signaling","2.08E-01","2.38E-02","NaN","TNFRSF13B"]
["Thyroid Hormone Metabolism II (via Conjugation and/or Degradation)","2.08E-01","2.38E-02","NaN","SULT1A2"]
["Acetone Degradation I (to Methylglyoxal)","2.08E-01","2.38E-02","NaN","CYP2C8"]
["Oncostatin M Signaling","2.02E-01","2.33E-02","NaN","STAT1"]
["TBC/RABGAPs","1.96E-01","2.27E-02","NaN","TBC1D13"]
["Collagen chain trimerization","1.96E-01","2.27E-02","NaN","COL17A1"]
["NAD Signaling Pathway",{"v":0,"d":"0.00E+00"},"1.32E-02","NaN","H1-5,H2BC17"]
["CSDE1 Signaling Pathway",{"v":0,"d":"0.00E+00"},"1.79E-02","NaN","PIWIL4"]
["Oxytocin in Brain Signaling Pathway",{"v":0,"d":"0.00E+00"},"1.99E-02",0,"CACNG2,CASP5,CREB5,PLB1"]
["CLEAR Signaling Pathway",{"v":0,"d":"0.00E+00"},"1.05E-02","NaN","CREB5,CTSD,RRAGD"]
["SNARE Signaling Pathway",{"v":0,"d":"0.00E+00"},"2.21E-02","NaN","MYL9,PRKAR1B,RAB39A"]
["MicroRNA Biogenesis Signaling Pathway",{"v":0,"d":"0.00E+00"},"5.29E-03","NaN","PIWIL4"]
["Neuregulin Signaling",{"v":0,"d":"0.00E+00"},"8.55E-03","NaN","DLG4"]
["Axonal Guidance Signaling",{"v":0,"d":"0.00E+00"},"2.15E-02","NaN","ADAM19,ARPC1B,EPHA1,GNA15,LIMK2,MMP8,MYL9,PLCL1,PRKAR1B,SEMA3G,SEMA7A"]
["Actin Cytoskeleton Signaling",{"v":0,"d":"0.00E+00"},"1.63E-02",2,"ARPC1B,LIMK2,MYL9,WASF1"]
["Synaptic Long Term Depression",{"v":0,"d":"0.00E+00"},"2.02E-02",0,"CACNG2,GNA15,PLB1,PLCL1"]
["Chaperone Mediated Autophagy Signaling Pathway",{"v":0,"d":"0.00E+00"},"1.73E-02",-0.302,"CCND1,CHEK1,FCER1G,HSPA1A/HSPA1B,HSPA6,IL18,MMP8,PSMB9,PSME2,SNX10,UCHL1"]
["ABRA Signaling Pathway",{"v":0,"d":"0.00E+00"},"2.17E-02","NaN","LIMK2,MYL9"]
["WNK Renal Signaling Pathway",{"v":0,"d":"0.00E+00"},"1.89E-02","NaN","KCNJ10,NR3C2"]
["GABAergic Receptor Signaling Pathway (Enhanced)",{"v":0,"d":"0.00E+00"},"2.16E-02","NaN","CACNG2,GRIN3A,PRKAR1B"]
["Glutaminergic Receptor Signaling Pathway (Enhanced)",{"v":0,"d":"0.00E+00"},"2.14E-02",0.378,"CACNG2,CAMK4,CREB5,GRIN3A,PLB1,PLCL1,PRKAR1B"]
["NFKBIE Signaling Pathway",{"v":0,"d":"0.00E+00"},"1.11E-02",1.342,"CXCL8,DYSF,FCER1G,TNFSF10,TNFSF13B"]
["Orexin Signaling Pathway",{"v":0,"d":"0.00E+00"},"1.25E-02","NaN","CACNG2,PLCL1,PRKAR1B"]
["Sertoli Cell-Germ Cell Junction Signaling Pathway (Enhanced)",{"v":0,"d":"0.00E+00"},"2.1E-02",2.236,"ARPC1B,CLDN11,JAM2,MMP8,PRKAR1B"]
["NRF2-mediated Oxidative Stress Response",{"v":0,"d":"0.00E+00"},"8.37E-03","NaN","CYP2C8,GSTM5"]
["Intrinsic Pathway for Apoptosis",{"v":0,"d":"0.00E+00"},"1.82E-02","NaN","E2F1"]
["Circadian Clock",{"v":0,"d":"0.00E+00"},"1.69E-02","NaN","SMARCD3"]
["Glycerophospholipid biosynthesis",{"v":0,"d":"0.00E+00"},"2.02E-02","NaN","AGPAT1,OSBPL10"]
["PI Metabolism",{"v":0,"d":"0.00E+00"},"1.22E-02","NaN","INPP5F"]
["Electron transport, ATP synthesis, and heat production by uncoupling proteins",{"v":0,"d":"0.00E+00"},"1.56E-02","NaN","COQ10A,NDUFAF3"]
["Collagen biosynthesis and modifying enzymes",{"v":0,"d":"0.00E+00"},"1.49E-02","NaN","COL17A1"]
["Cytosolic sensors of pathogen-associated DNA",{"v":0,"d":"0.00E+00"},"2.17E-02","NaN","AIM2"]
["p75 NTR receptor-mediated signalling",{"v":0,"d":"0.00E+00"},"1E-02","NaN","PSENEN"]
["Metabolism of non-coding RNA",{"v":0,"d":"0.00E+00"},"1.82E-02","NaN","RNU5B-1"]
["Generic Transcription Pathway",{"v":0,"d":"0.00E+00"},"1.64E-02",-2.646,"NR3C2,THRB,ZNF112,ZNF14,ZNF2,ZNF799,ZNF860"]
["RNA Polymerase II Transcription",{"v":0,"d":"0.00E+00"},"6.71E-03","NaN","DDX39B"]
["COPII-mediated vesicle transport",{"v":0,"d":"0.00E+00"},"1.39E-02","NaN","TRAPPC5"]
["MHC class II antigen presentation",{"v":0,"d":"0.00E+00"},"1.59E-02","NaN","CTSD,KIF2C"]
["Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer",{"v":0,"d":"0.00E+00"},"2.04E-02","NaN","STAT1"]
["Selenoamino acid metabolism",{"v":0,"d":"0.00E+00"},"9.35E-03","NaN","NNMT"]
["Fc epsilon receptor (FCERI) signaling",{"v":0,"d":"0.00E+00"},"1.94E-02",1,"FCER1A,FCER1G,PSMB9,PSME2"]
["Class B/2 (Secretin family receptors)",{"v":0,"d":"0.00E+00"},"1.05E-02","NaN","GNG8"]
["L1CAM interactions",{"v":0,"d":"0.00E+00"},"1.6E-02","NaN","CD24,DLG4"]
["Regulation of lipid metabolism by PPARalpha",{"v":0,"d":"0.00E+00"},"1.68E-02","NaN","ALAS1,SMARCD3"]
["G alpha (12/13) signalling events",{"v":0,"d":"0.00E+00"},"1.25E-02","NaN","GNG8"]
["G alpha (s) signalling events",{"v":0,"d":"0.00E+00"},"2.07E-02","NaN","GNG8,PDE7B,POMC"]
["G alpha (z) signalling events",{"v":0,"d":"0.00E+00"},"2.08E-02","NaN","GNG8"]
["Transport of inorganic cations/anions and amino acids/oligopeptides",{"v":0,"d":"0.00E+00"},"1.92E-02","NaN","SLC26A11,SLC34A2"]
["Sphingolipid metabolism",{"v":0,"d":"0.00E+00"},"1.15E-02","NaN","SMPD1"]
["SUMOylation of DNA replication proteins",{"v":0,"d":"0.00E+00"},"2.22E-02","NaN","BIRC5"]
["Interleukin-3, Interleukin-5 and GM-CSF signaling",{"v":0,"d":"0.00E+00"},"1.82E-02","NaN","INPP5F"]
["Cilium Assembly",{"v":0,"d":"0.00E+00"},"9.95E-03","NaN","CDK1,PLK1"]
["RAF/MAP kinase cascade",{"v":0,"d":"0.00E+00"},"1.91E-02",2.236,"DLG4,FGA,FGB,PSMB9,PSME2"]
["Major pathway of rRNA processing in the nucleolus and cytosol",{"v":0,"d":"0.00E+00"},"5.38E-03","NaN","SNORD3A"]
["TP53 Regulates Transcription of DNA Repair Genes",{"v":0,"d":"0.00E+00"},"1.43E-02","NaN","CHEK1"]
["Keratinization",{"v":0,"d":"0.00E+00"},"1.4E-02","NaN","CSTA,FLG,KRT1"]
["PTEN Regulation",{"v":0,"d":"0.00E+00"},"2E-02","NaN","PSMB9,PSME2,RRAGD"]
["Intra-Golgi and retrograde Golgi-to-ER traffic",{"v":0,"d":"0.00E+00"},"9.85E-03","NaN","KIF2C,RAB39A"]
["Processing of Capped Intron-Containing Pre-mRNA",{"v":0,"d":"0.00E+00"},"6.97E-03","NaN","DDX39B,RNU5B-1"]
["DNA Damage Bypass",{"v":0,"d":"0.00E+00"},"2.08E-02","NaN","UBE2L6"]
["Cargo recognition for clathrin-mediated endocytosis",{"v":0,"d":"0.00E+00"},"1.87E-02","NaN","CLTCL1,IL7R"]
["Clathrin-mediated endocytosis",{"v":0,"d":"0.00E+00"},"1.54E-02","NaN","CLTCL1,IL7R"]
["RAB GEFs exchange GTP for GDP on RABs",{"v":0,"d":"0.00E+00"},"2.25E-02","NaN","RAB39A,TRAPPC5"]
["Carboxyterminal post-translational modifications of tubulin",{"v":0,"d":"0.00E+00"},"2.22E-02","NaN","TTLL11"]
["Transcriptional Regulation by MECP2",{"v":0,"d":"0.00E+00"},"1.59E-02","NaN","CAMK4"]
["RHO GTPase cycle",{"v":0,"d":"0.00E+00"},"1.56E-02",1.134,"CIT,DDX39B,FILIP1,LMNB1,NCF1,NCF4,WASF1"]
["NR1H2 and NR1H3-mediated signaling",{"v":0,"d":"0.00E+00"},"2E-02","NaN","CETP"]
["Amino acids regulate mTORC1",{"v":0,"d":"0.00E+00"},"1.82E-02","NaN","RRAGD"]
["Sensory processing of sound by outer hair cells of the cochlea",{"v":0,"d":"0.00E+00"},"1.82E-02","NaN","KCNMA1"]
["Heme signaling",{"v":0,"d":"0.00E+00"},"2.17E-02","NaN","SMARCD3"]
["Sensory perception of taste",{"v":0,"d":"0.00E+00"},"2.13E-02","NaN","KCNJ2"]
["KEAP1-NFE2L2 pathway",{"v":0,"d":"0.00E+00"},"2.2E-02","NaN","PSMB9,PSME2"]
["Kinesins",{"v":0,"d":"0.00E+00"},"1.64E-02","NaN","KIF2C"]
["Signaling by the B Cell Receptor (BCR)",{"v":0,"d":"0.00E+00"},"1.76E-02","NaN","CD79B,PSMB9,PSME2"]
["Ion channel transport",{"v":0,"d":"0.00E+00"},"2.19E-02",0,"ANO9,ATP2B1,ATP7B,TTYH3"]
["Pancreatic Secretion Signaling Pathway",{"v":0,"d":"0.00E+00"},"2.01E-02",-0.447,"ATP2B1,KCNMA1,LPL,PLCL1,PRKAR1B"]
["Protein Sorting Signaling Pathway",{"v":0,"d":"0.00E+00"},"1.69E-02","NaN","CLTCL1,PRKAR1B,SNX10"]
["Tight Junction Signaling",{"v":0,"d":"0.00E+00"},"2.22E-02","NaN","CLDN11,JAM2,MYL9,PRKAR1B"]
["14-3-3-mediated Signaling",{"v":0,"d":"0.00E+00"},"7.75E-03","NaN","PLCL1"]
["Role of NFAT in Regulation of the Immune Response",{"v":0,"d":"0.00E+00"},"8.67E-03",1.414,"CD79B,FCER1A,FCER1G,FCGR1A,FCGR2A,FCGR3A/FCGR3B,GNA15,HLA-A,LOC102723407"]
["FcŒ≥RIIB Signaling in B Lymphocytes",{"v":0,"d":"0.00E+00"},"5.61E-03","NaN","CACNG2,CD79B,LOC102723407"]
["CCR5 Signaling in Macrophages",{"v":0,"d":"0.00E+00"},"6.01E-03","NaN","CACNG2,FCER1G,GNA15"]
["Calcium-induced T Lymphocyte Apoptosis",{"v":0,"d":"0.00E+00"},"4.35E-03","NaN","FCER1G,HLA-A"]
["Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells",{"v":0,"d":"0.00E+00"},"4.71E-03","NaN","FCER1G,HLA-A"]
["CD27 Signaling in Lymphocytes",{"v":0,"d":"0.00E+00"},"1.75E-02","NaN","CD27"]
["IL-3 Signaling",{"v":0,"d":"0.00E+00"},"1.23E-02","NaN","STAT1"]
["CXCR4 Signaling",{"v":0,"d":"0.00E+00"},"1.18E-02","NaN","GNA15,MYL9"]
["Thrombopoietin Signaling",{"v":0,"d":"0.00E+00"},"1.54E-02","NaN","STAT1"]
["CTLA4 Signaling in Cytotoxic T Lymphocytes",{"v":0,"d":"0.00E+00"},"4.92E-03","NaN","CLTCL1,FCER1G,HLA-A"]
["T Helper Cell Differentiation",{"v":0,"d":"0.00E+00"},"8.49E-03","NaN","FCER1G,HLA-A,IL18,STAT1"]
["CCR3 Signaling in Eosinophils",{"v":0,"d":"0.00E+00"},"1.47E-02","NaN","GNA15,LIMK2"]
["CD28 Signaling in T Helper Cells",{"v":0,"d":"0.00E+00"},"5.78E-03","NaN","ARPC1B,FCER1G,HLA-A"]
["IL-15 Signaling",{"v":0,"d":"0.00E+00"},"3.77E-03","NaN","CXCL8,LOC102723407"]
["Virus Entry via Endocytic Pathways",{"v":0,"d":"0.00E+00"},"1.67E-02","NaN","CLTCL1,HLA-A"]
["Dendritic Cell Maturation",{"v":0,"d":"0.00E+00"},"1.84E-02",1.265,"CD1C,CREB5,FCER1G,FCGR1A,FCGR2A,FCGR3A/FCGR3B,HLA-A,IL18,IL23A,PLCL1,STAT1"]
["Angiopoietin Signaling",{"v":0,"d":"0.00E+00"},"1.28E-02","NaN","BIRC5"]
["CNTF Signaling",{"v":0,"d":"0.00E+00"},"1.69E-02","NaN","STAT1"]
["Renin-Angiotensin Signaling",{"v":0,"d":"0.00E+00"},"1.63E-02","NaN","PRKAR1B,STAT1"]
["Thrombin Signaling",{"v":0,"d":"0.00E+00"},"1.76E-02","NaN","CAMK4,GNA15,MYL9,PLCL1"]
["CDK5 Signaling",{"v":0,"d":"0.00E+00"},"8.7E-03","NaN","PRKAR1B"]
["ICOS-ICOSL Signaling in T Helper Cells",{"v":0,"d":"0.00E+00"},"3.93E-03","NaN","FCER1G,HLA-A"]
["Lipid Antigen Presentation by CD1",{"v":0,"d":"0.00E+00"},"4.82E-03","NaN","CD1C,FCER1G"]
["HGF Signaling",{"v":0,"d":"0.00E+00"},"7.46E-03","NaN","CCND1"]
["Polyamine Regulation in Colon Cancer",{"v":0,"d":"0.00E+00"},"1.69E-02","NaN","ARG1"]
["GNRH Signaling",{"v":0,"d":"0.00E+00"},"2.09E-02","NaN","CACNG2,CREB5,GNA15,PRKAR1B"]
["Cholecystokinin/Gastrin-mediated Signaling",{"v":0,"d":"0.00E+00"},"8.4E-03","NaN","IL18"]
["Human Embryonic Stem Cell Pluripotency",{"v":0,"d":"0.00E+00"},"9.85E-03","NaN","FGFRL1,S1PR2"]
["Role of OCT4 in Mammalian Embryonic Stem Cell Pluripotency",{"v":0,"d":"0.00E+00"},"2.17E-02","NaN","SPP1"]
["Germ Cell-Sertoli Cell Junction Signaling",{"v":0,"d":"0.00E+00"},"5.81E-03","NaN","LIMK2"]
["Renal Cell Carcinoma Signaling",{"v":0,"d":"0.00E+00"},"1.23E-02","NaN","SLC2A1"]
["Type I Diabetes Mellitus Signaling",{"v":0,"d":"0.00E+00"},"1.18E-02",0.447,"FCER1G,HLA-A,IRF1,SOCS1,SOCS3,STAT1"]
["Small Cell Lung Cancer Signaling",{"v":0,"d":"0.00E+00"},"2.04E-02","NaN","CCND1,E2F1"]
["Allograft Rejection Signaling",{"v":0,"d":"0.00E+00"},"4.11E-03","NaN","FCER1G,HLA-A"]
["Autoimmune Thyroid Disease Signaling",{"v":0,"d":"0.00E+00"},"4.37E-03","NaN","FCER1G,HLA-A"]
["Graft-versus-Host Disease Signaling",{"v":0,"d":"0.00E+00"},"6.73E-03","NaN","FCER1G,HLA-A,IL18"]
["Non-Small Cell Lung Cancer Signaling",{"v":0,"d":"0.00E+00"},"2.08E-02","NaN","CCND1,E2F1"]
["GŒ±12/13 Signaling",{"v":0,"d":"0.00E+00"},"1.48E-02","NaN","CDH5,MYL9"]
["p70S6K Signaling",{"v":0,"d":"0.00E+00"},"5.15E-03","NaN","CD79B,LOC102723407,PLCL1"]
["ERK5 Signaling",{"v":0,"d":"0.00E+00"},"1.35E-02","NaN","CREB5"]
["MYC Mediated Apoptosis Signaling",{"v":0,"d":"0.00E+00"},"2E-02","NaN","PRKAR1B"]
["G Protein Signaling Mediated by Tubby",{"v":0,"d":"0.00E+00"},"6.41E-03","NaN","FCER1G,GNA15,THRB"]
["Communication between Innate and Adaptive Immune Cells",{"v":0,"d":"0.00E+00"},"9.65E-03","NaN","CD79B,CXCL10,CXCL8,FCER1G,HLA-A,IL18,LOC102723407,TNFRSF13B,TNFSF13B"]
["Systemic Lupus Erythematosus Signaling",{"v":0,"d":"0.00E+00"},"1.59E-02","NaN","CAMK4,CD79B,FCER1G,FCGR1A,FCGR2A,FCGR3A/FCGR3B,HLA-A,IL18,LOC102723407,RNU1-28P,RNU4-2,RNU5A-1,RNU5B-1,RNU5D-1,RNU5F-1,RNVU1-7,TNFSF13B"]
["CDC42 Signaling",{"v":0,"d":"0.00E+00"},"8.68E-03",2,"ARPC1B,FCER1G,HLA-A,LIMK2,MYL9"]
["FAK Signaling",{"v":0,"d":"0.00E+00"},"2.11E-02",-0.426,"APLNR,ARPC1B,C3AR1,CCND1,CDH5,CNR2,ECM1,FCER1G,FFAR2,FPR1,GPR183,GPR68,IL7R,LEF1,P2RY13,P2RY14,P2RY6,PTGDR2,S1PR2,SOCS1,SOCS3,TCF7"]
["EIF2 Signaling",{"v":0,"d":"0.00E+00"},"8.66E-03","NaN","CCND1,WARS1"]
["PAK Signaling",{"v":0,"d":"0.00E+00"},"1.68E-02","NaN","LIMK2,MYL9"]
["Phospholipase C Signaling",{"v":0,"d":"0.00E+00"},"6.24E-03",0.447,"CAMK4,CD79B,CREB5,FCER1G,FCGR2A,LOC102723407,MYL9"]
["HER-2 Signaling in Breast Cancer",{"v":0,"d":"0.00E+00"},"2.18E-02",0.447,"BIRC5,CCND1,COX7A1,FCER1A,FCER1G"]
["Altered T Cell and B Cell Signaling in Rheumatoid Arthritis",{"v":0,"d":"0.00E+00"},"1.06E-02","NaN","CD79B,FCER1G,HLA-A,IL18,IL23A,LOC102723407,PRTN3,SPP1,TNFRSF13B,TNFSF13B"]
["Role of NFAT in Cardiac Hypertrophy",{"v":0,"d":"0.00E+00"},"1.77E-02",-1,"CACNG2,CAMK4,PLCL1,PRKAR1B"]
["B Cell Development",{"v":0,"d":"0.00E+00"},"8.18E-03","NaN","CD79B,HLA-A,IL7R,LOC102723407"]
["IL-1 Signaling",{"v":0,"d":"0.00E+00"},"2.08E-02","NaN","GNA15,PRKAR1B"]
["Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes",{"v":0,"d":"0.00E+00"},"2.16E-03","NaN","FCER1G"]
["NUR77 Signaling in T Lymphocytes",{"v":0,"d":"0.00E+00"},"5.85E-03","NaN","FCER1G,HLA-A,TNFSF10"]
["PKCŒ∏ Signaling in T Lymphocytes",{"v":0,"d":"0.00E+00"},"5.36E-03","NaN","CACNG2,FCER1G,HLA-A"]
["Antiproliferative Role of TOB in T Cell Signaling",{"v":0,"d":"0.00E+00"},"4.69E-03","NaN","CCNA2,FCER1G"]
["OX40 Signaling Pathway",{"v":0,"d":"0.00E+00"},"4.18E-03","NaN","FCER1G,HLA-A"]
["PI3K Signaling in B Lymphocytes",{"v":0,"d":"0.00E+00"},"6.77E-03","NaN","CARD10,CD79B,LOC102723407,PLCL1"]
["Cell Cycle Control of Chromosomal Replication",{"v":0,"d":"0.00E+00"},"1.79E-02","NaN","CDK1"]
["Spliceosomal Cycle",{"v":0,"d":"0.00E+00"},"1.89E-02","NaN","DDX39B"]
["Role of IL-17A in Arthritis",{"v":0,"d":"0.00E+00"},"1.69E-02","NaN","CXCL8"]
["IL-17A Signaling in Fibroblasts",{"v":0,"d":"0.00E+00"},"1.15E-02","NaN","IL23A"]
["Actin Nucleation by ARP-WASP Complex",{"v":0,"d":"0.00E+00"},"2.15E-02","NaN","ARPC1B,WASF1"]
["NGF Signaling",{"v":0,"d":"0.00E+00"},"1.64E-02","NaN","CREB5,SMPD1"]
["Sertoli Cell-Sertoli Cell Junction Signaling",{"v":0,"d":"0.00E+00"},"1.63E-02",-1,"CDH5,CLDN11,CREB5,JAM2"]
["Gap Junction Signaling",{"v":0,"d":"0.00E+00"},"1.5E-02","NaN","GJA5,PLCL1,PRKAR1B"]
["Telomerase Signaling",{"v":0,"d":"0.00E+00"},"9.09E-03","NaN","E2F1"]
["Mouse Embryonic Stem Cell Pluripotency",{"v":0,"d":"0.00E+00"},"1.89E-02","NaN","LEF1,TCF7"]
["Hematopoiesis from Pluripotent Stem Cells",{"v":0,"d":"0.00E+00"},"4.48E-03","NaN","CXCL8,FCER1G"]
["Transcriptional Regulatory Network in Embryonic Stem Cells",{"v":0,"d":"0.00E+00"},"1.82E-02","NaN","FGFRL1,IGF2,ZFHX3"]
["nNOS Signaling in Skeletal Muscle Cells",{"v":0,"d":"0.00E+00"},"2.08E-02","NaN","CACNG2"]
["Ephrin A Signaling",{"v":0,"d":"0.00E+00"},"2.04E-02","NaN","EPHA1"]
["Ephrin B Signaling",{"v":0,"d":"0.00E+00"},"1.39E-02","NaN","GNA15"]
["ERB2-ERBB3 Signaling",{"v":0,"d":"0.00E+00"},"1.49E-02","NaN","CCND1"]
["ERBB4 Signaling",{"v":0,"d":"0.00E+00"},"1.43E-02","NaN","PSENEN"]
["GDNF Family Ligand-Receptor Interactions",{"v":0,"d":"0.00E+00"},"1.3E-02","NaN","DOK7"]
["Heparan Sulfate Biosynthesis",{"v":0,"d":"0.00E+00"},"2.22E-02","NaN","SULT1A2,TNFAIP6"]
["Nicotine Degradation III",{"v":0,"d":"0.00E+00"},"1.67E-02","NaN","CYP2C8"]
["Estrogen Biosynthesis",{"v":0,"d":"0.00E+00"},"2.17E-02","NaN","CYP2C8"]
["Chondroitin Sulfate Biosynthesis",{"v":0,"d":"0.00E+00"},"1.64E-02","NaN","SULT1A2"]
["Dermatan Sulfate Biosynthesis",{"v":0,"d":"0.00E+00"},"1.59E-02","NaN","SULT1A2"]
["Dermatan Sulfate Biosynthesis (Late Stages)",{"v":0,"d":"0.00E+00"},"2E-02","NaN","SULT1A2"]
["Nicotine Degradation II",{"v":0,"d":"0.00E+00"},"1.47E-02","NaN","CYP2C8"]
["Chondroitin Sulfate Biosynthesis (Late Stages)",{"v":0,"d":"0.00E+00"},"1.89E-02","NaN","SULT1A2"]
["Stearate Biosynthesis I (Animals)",{"v":0,"d":"0.00E+00"},"1.41E-02","NaN","ACOT7"]
["GŒ±q Signaling",{"v":0,"d":"0.00E+00"},"5.81E-03","NaN","GNA15"]
["Remodeling of Epithelial Adherens Junctions",{"v":0,"d":"0.00E+00"},"1.47E-02","NaN","ARPC1B"]
["Sperm Motility",{"v":0,"d":"0.00E+00"},"1.95E-02","NaN","EPHA1,GNA15,PLB1,PLCL1,PRKAR1B"]
["TEC Kinase Signaling",{"v":0,"d":"0.00E+00"},"1.03E-02",0,"FCER1A,FCER1G,GNA15,STAT1,TNFRSF10A,TNFSF10"]
["UVB-Induced MAPK Signaling",{"v":0,"d":"0.00E+00"},"1.85E-02","NaN","H3C3"]
["UVC-Induced MAPK Signaling",{"v":0,"d":"0.00E+00"},"1.96E-02","NaN","SMPD1"]
["Oxidative Phosphorylation",{"v":0,"d":"0.00E+00"},"8.93E-03","NaN","COX7A1"]
["HIPPO signaling",{"v":0,"d":"0.00E+00"},"1.16E-02","NaN","DLG4"]
["Toll-like Receptor Signaling",{"v":0,"d":"0.00E+00"},"1.28E-02","NaN","IL18"]
["EGF Signaling",{"v":0,"d":"0.00E+00"},"1.72E-02","NaN","STAT1"]
["SAPK/JNK Signaling",{"v":0,"d":"0.00E+00"},"1.99E-03","NaN","FCER1G"]
["PI3K/AKT Signaling",{"v":0,"d":"0.00E+00"},"1.5E-02","NaN","CCND1,IL7R,INPP5F"]
["PTEN Signaling",{"v":0,"d":"0.00E+00"},"1.32E-02","NaN","CCND1,INPP5F"]
["Nitric Oxide Signaling in the Cardiovascular System",{"v":0,"d":"0.00E+00"},"1.64E-02","NaN","CACNG2,PRKAR1B"]
["IL-2 Signaling",{"v":0,"d":"0.00E+00"},"1.56E-02","NaN","SOCS1"]
["GABA Receptor Signaling",{"v":0,"d":"0.00E+00"},"1.52E-02","NaN","CACNG2,GNA15"]
["Xenobiotic Metabolism Signaling",{"v":0,"d":"0.00E+00"},"1.69E-02","NaN","ALDH1A1,CAMK4,CYP2C8,GSTM5,SULT1A2"]
["IL-4 Signaling",{"v":0,"d":"0.00E+00"},"1.21E-02",1.134,"ARG1,COL17A1,CREB5,FCER1G,GFI1,PTGDR2,SOCS1"]
["B Cell Receptor Signaling",{"v":0,"d":"0.00E+00"},"9.42E-03",0,"CARD10,CD79B,CREB5,FCGR2A,INPP5F,LOC102723407"]
["Insulin Receptor Signaling",{"v":0,"d":"0.00E+00"},"2.14E-02","NaN","INPP5F,PRKAR1B,SOCS3"]
["Phototransduction Pathway",{"v":0,"d":"0.00E+00"},"1.85E-02","NaN","PRKAR1B"]
["Neurotrophin/TRK Signaling",{"v":0,"d":"0.00E+00"},"1.25E-02","NaN","CREB5"]
["Integrin Signaling",{"v":0,"d":"0.00E+00"},"9.35E-03","NaN","ARPC1B,MYL9"]
["PPAR Signaling",{"v":0,"d":"0.00E+00"},"9.35E-03","NaN","IL18"]
["Dopamine Receptor Signaling",{"v":0,"d":"0.00E+00"},"1.25E-02","NaN","PRKAR1B"]
["Apoptosis Signaling",{"v":0,"d":"0.00E+00"},"9.62E-03","NaN","CDK1"]
["NF-Œ∫B Signaling",{"v":0,"d":"0.00E+00"},"6.99E-03",1,"CARD10,FCER1G,IL18,TNFSF13B"]
["T Cell Receptor Signaling",{"v":0,"d":"0.00E+00"},"6.47E-03",0,"FCER1G,HLA-A,LEF1,TCF7"]
["PDGF Signaling",{"v":0,"d":"0.00E+00"},"2.25E-02","NaN","INPP5F,STAT1"]
["Autophagy",{"v":0,"d":"0.00E+00"},"1.84E-02",2,"CREB5,E2F1,MAP1LC3A,PRKAR1B"]
["Sumoylation Pathway",{"v":0,"d":"0.00E+00"},"1.94E-02","NaN","MYB,ZEB1"]
["Adrenomedullin signaling pathway",{"v":0,"d":"0.00E+00"},"1.99E-02",1,"GNA15,IL18,PLCL1,PRKAR1B"]
["Iron homeostasis signaling pathway",{"v":0,"d":"0.00E+00"},"7.3E-03","NaN","FECH"]
["Th17 Activation Pathway",{"v":0,"d":"0.00E+00"},"6.2E-03","NaN","FCER1G,IL23A,SOCS3"]
["SPINK1 General Cancer Pathway",{"v":0,"d":"0.00E+00"},"1.41E-02","NaN","MT1X"]
["Apelin Endothelial Signaling Pathway",{"v":0,"d":"0.00E+00"},"1.4E-02","NaN","APLNR,GNA15"]
["T Cell Exhaustion Signaling Pathway",{"v":0,"d":"0.00E+00"},"1.05E-02",2.236,"CD274,FCER1G,HLA-A,PDCD1LG2,STAT1,TCF7"]
["Systemic Lupus Erythematosus in T Cell Signaling Pathway",{"v":0,"d":"0.00E+00"},"9.3E-03",-0.816,"CAMK4,CASP5,CREB5,FCER1G,HLA-A,IL23A"]
["Systemic Lupus Erythematosus in B Cell Signaling Pathway",{"v":0,"d":"0.00E+00"},"2.06E-02",0.535,"CCND1,CD5,CD79B,CLCF1,CXCL8,FCGR2A,IFIT2,IFIT3,IL18,INPP5F,LILRB4,LOC102723407,STAT1,TNFSF10,TNFSF13B"]
["Xenobiotic Metabolism General Signaling Pathway",{"v":0,"d":"0.00E+00"},"6.9E-03","NaN","GSTM5"]
["Xenobiotic Metabolism CAR Signaling Pathway",{"v":0,"d":"0.00E+00"},"2.06E-02",1,"ALDH1A1,CYP2C8,GSTM5,SULT1A2"]
["Eicosanoid Signaling",{"v":0,"d":"0.00E+00"},"1.43E-02","NaN","PLB1"]
["Role of MAPK Signaling in Promoting the Pathogenesis of Influenza",{"v":0,"d":"0.00E+00"},"8.77E-03","NaN","PLB1"]